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The nucleus incertus (NI) was identified as a distinct group of cells in the pontine 
periventricular gray, near the fourth ventricle of the rats’ brains. Lack of definitive 
knowledge about the characteristics and functions of this nucleus led to it being 
named the nucleus incertus, latin for “uncertain nucleus”. Presence of the inhibitory 
amino acid transmitter, γ-aminobutyric acid (GABA), revealed by the expression of 
glutamate decarboxylase 2 (GAD2 or GAD65) in the NI suggests that the 
neurotransmission from the NI is primarily inhibitory.  In particular, expression of 
relaxin-3 is highly concentrated in the NI.  Interest in the connections and 
neurochemistry of the NI spiked after it was discovered that the cells in the rat NI 
express high levels of corticotropin releasing hormone receptor 1 (CRF1) and were 
activated in response to intracerebroventricular (ICV) infusions of CRF. CRF1 is 
known to play a role in the circuitry of stress and anxiety response, thereby possibly 
implicating the NI in similar behavioural reactions to stress and anxiety.  
 
The extensive projections of the NI neurons places the NI in a strategic position to 
control multiple neural circuits involved in several physiological functions, ranging 
from influencing cognitive function to modulation of stress, anxiety, depression and 
regulation of appetite. To further investigate the role of the NI in appetite and anxiety 
regulation, this thesis first aims to establish a method using the CRF-saporin 
conjugate to selectively target and ablate the NI neurons in rats. The effect of this loss 
of NI neurons on feeding and anxiety behaviour in rats will then be examined. 
Clearly, relaxin-3 expression is highly restricted in the NI, therefore, this project also 
aims to question if relaxin-3 is indeed the neuropeptide orchestrating the actions of 




The findings showed a marked reduction of CRF1, relaxin-3 and GAD65 while THP2 
expression was unchanged, indicating that CRF-saporin selectively targets and lesions 
the CRF1-expressing neurons in the NI. NI-lesioned rats displayed elevated levels of 
anxiogenic-like behaviour in fear conditioning, large open field, elevated plus maze, 
novelty suppressed feeding and the light-dark box (compared to sham lesioned rats), 
which may be attributed to the loss of NI neurons.  As there were several reports on 
the anxiolytic nature of relaxin-3, the effects of human relaxin-3 infusion into the 
medial and central amygdala of the NI-lesioned rats were also studied. The results 
revealed that H3 infusion in the medial/central amygdala produced an anxiolytic-like 
behaviour, effectively “rescuing” the anxious phenotype of the NI-lesioned rats. 
Collectively, these results proposed that the NI possibly exerts its modulatory role on 
anxiety-like behaviour via the relaxin-3 projections and interaction with the medial 
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SALPR  Somatostatin- and angiotensin-like peptide receptor 
SON   supraoptic nucleus 
TPH2   Tryptophan hydroxylase 2 
VMH   Ventromedial hypothalamus 
α-MSH  α-melanocyte stimulating hormone 
 
 





1.1 Psychiatric and affective disorders 
 
Despite the advances in our knowledge of mental illnesses and treatments, mental 
disorders remain a huge problem in the modern society. In 2001, the world health 
organisation (WHO) reported that an estimated 450 million individuals suffer from a 
neuropsychiatric disorder at least once in their lifetime. Approximately half of the 
mental disorders begin even before the age of 14. Mental illness can range from mild 
temporary disorders to severe and prolonged illnesses. Unfortunately, 
neuropsychiatric disorders may lead to serious consequences on a patient’s health, 
ranging from minor reductions in coping with life’s ordinary demands and routines, to 
complete debilitation such as rejection from family, friends and even employers, and 
in some cases even leading to death (Chong, 2007). This situation is expected to 
worsen, with the global problems attributed to mental disorders expected to rise from 
12.3% in 2000 to 14.7% in 2020 and unipolar depression being the most common 
cause of disability, second only to anxiety (Murray and Lopez, 1997). 
 
A 2012 household survey study reported that 12.0% of adults in Singapore had a 
mental disorder at one point in their life, which included generalised anxiety disorder 
(GAD), obsessive compulsive disorder (OCD), major depressive disorder, bipolar 
disorder, alcohol abuse and dependence (Chong et al., 2012). About 3.3% of adults in 
Singapore had an occurrence of GAD, which seemed to increase in older individuals 
(Lim et al., 2005). Throughout history, the public stigma against people with mental 
illness has hindered them from leading a normal life.  The burden for care for 
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mentally ill patients rests almost entirely on the specialized services in the private and 
public healthcare sector.  
 
In consideration of the fact that anxiety and depression are by far the most common 
mental disorders, it is imperative to better understand and elucidate the neural circuits 
that contribute to these illnesses. Moreover a study in a multi-ethnic adult Asian 
population had found increased correlations of low body mass index (BMI) and a 
lifetime occurrence of anxiety. The lifetime prevalence of obsessive compulsive 
disorder (OCD) was 4.7% among underweight people as compared to 2.6% in the 
normal control group while 3.0% of the underweight group had a 12-month 
occurrence of generalized anxiety disorder (GAD) when compared against 1.5% of 
the normal BMI group, thereby hinting that appetite regulation may be associated 
with anxiety. Interestingly, obesity was also associated with an increase in 12-month 
alcohol dependence (Subramaniam et al., 2012). There are striking similarities 
between OCD and eating disorders and it has been suggested that anorexia nervosa is 
perhaps a modern variant of OCD, in which patients are often engaged in compulsive 
dieting, weight checking and exercising to achieve a certain body weight (Hsu et al., 
1993).  
 
There is an urgent need to understand neural circuits contributing to these mental 
disorders, and thereafter, develop improved treatments to mitigate the disturbing 
increase in prevalence of mental illnesses emerging in the present society. The 
tremendous advances in neuroscience in the present era makes it possible to 
investigate the intricate neural connections in regions of the brain potentially 
implicated in anxiety and appetite regulation. As the causes and overlapping 
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~700µm and is divided into the ‘pars compacta’ and the ‘pars dissipata’; the former 
containing closely packed medium sized multipolar neurons (Goto et al., 2001; 
Paxinos and Watsons 2007). The pars dissipata (NId) extends horizontally from the 
pars compacta (NIc) and spans its entire rostracaudal length.  The NId consists of a 
cluster of loosely arranged neurons that shares similar chemoarchitecture with the 
NIc. The cross-sectional area of the NI increases towards the caudal end of the central 
grey (Goto et al., 2001).  
 
Lack of definitive knowledge about the characteristics and functions of this nucleus 
led to it being named the nucleus incertus, latin for “uncertain nucleus”. Research is 
still being carried out to characterize the neurochemistry and function of the NI in 
other species. In the mouse brain, the NI occupies a more ventral position from the 
fourth ventricle and does not have a distinct separation of the pars compacta and pars 
dissipata (Paxinos and Watsons, 2006; Gundlach et al., 2009; Smith et al., 2009b, 
2010). The primate analogue of the NI was described in the macaque brain to contain 
large relaxin-3 positive neurons found within the ventromedial central gray (Ma et al., 
2009b), though the NI neurons are somewhat more dispersed as compared to the 
mouse and rat. The discovery of the possible equivalent of the NI in zebrafish 
(Donizetti et al., 2008) seem to suggest a conserved functional significance of this 
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1.3 Neurotransmitters, neuropeptides and receptors in the nucleus incertus 
 
Presence of the inhibitory amino acid transmitter, γ-aminobutyric acid (GABA), 
revealed by the expression of glutamate decarboxylase 2 (GAD2 or GAD65) in the NI 
suggests that the neurotransmission from the NI is primarily inhibitory. Unlike other 
GABAergic neurons in the brainstem, the GABAergic neurons in the NI are larger 
and have longer projections (Ford et al., 1995; Ma et al., 2007). Expression of various 
neuropeptides have also been reported, including neurotensin (Jennes et al. 1982), 
neuromedin B, a ranatensin-like peptide (Chronwall et al. 1985; Wada et al. 1990), 
galanin, dynorphin (Sutin & Jacobowitz 1988), calbindin, calretinin (Paxinos 1999), 
cholecystokinin (CCK) (Olucha-Bordonau et al. 2003) and relaxin-3 (Bathgate et al. 
2002).  
 
In particular, expression of relaxin-3 is highly concentrated in the NI and found only 
in a small number of neurons in a few other regions such as the pontine raphe nucleus, 
periaqueductal gray and dorsal substantia nigra (Goto et al. 2001; Bathgate et al. 
2002; Burazin et al. 2002; Liu et al., 2003b; Tanaka et al. 2005). This is in contrast to 
the extensive expression of neuromedin B and CCK in the brain, which are thus not as 
specific in defining the NI. As such, the NI is considered the principle source of 
relaxin-3 in the brain and possibly serves as a key point of regulation of the relaxin-3 
neural circuitry. Separate immunohistochemical studies have also reported that the 
relaxin-3 positive NI neurons in rats also express the GABA-synthesizing enzyme, 
glutamate decarboxylase (GAD) (Ford et al. 1995; Olucha-Bordonau et al. 2003). 
Subsequently, double immuno-labelling experiments in rats indicated that all the 
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relaxin-3 neurons in the NI co-express corticotropin releasing hormone receptor 1 
(CRF1) (Tanaka et al. 2005).  
 
Interest in the connections and neurochemistry of the NI spiked after it was 
discovered that the cells in the rat NI express high levels of CRF1 and were activated 
in response to intracerebroventricular (ICV) infusions of CRF (Potter et al. 1994; 
Bittencourt and Sawchenko 2000; Tanaka et al. 2005). CRF1 is known to play a role 
in the circuitry of stress and anxiety response, thereby possibly implicating the NI in 
similar behavioural reactions to stress.  Subsequent studies have reported the presence 
of other receptors in the nucleus incertus, 5-hydroxytryptamine receptor 1A (5-HT1A) 
(Miyamoto et al. 2008) and the glutamate metabotropic receptor 3 (mGluR3) (Ma et 
al., 2007). 
 
1.4 Relaxin-3 and its receptor 
 
Relaxin-3, the most recently discovered member of the relaxin/insulin-like family of 
peptides, was identified only in the last decade through its homology to H1 and H2 
relaxin.  This family of peptides is characterized by the presence of two peptide 
subunits held together by three disulphide bonds. Despite its later discovery, relaxin-3 
is thought to be the ancestral gene in the family (Wilkinson et al., 2005), with a high 
degree of amino acid sequence conservation across many mammalian species 
including mice, rats, pigs, primates and humans (van der Westhuizen et al., 2008; 
Silvertown et al., 2009). The conservation of relaxin-3 suggests important and 
fundamental functions in the brain.  
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Additional studies have also identified an extensive network of relaxin-3 
immunoreactive fibers throughout the rat brain (Tanaka et al. 2005; Ma et al. 2007) 
and electron microscopy revealed that relaxin-3 is translated in the rough endoplasmic 
reticulum, packaged into dense-core vesicles and trafficked to pre-synaptic terminals 
of the axons (Tanaka et al. 2005), consistent with relaxin-3 functioning as a 
neurotransmitter or neuromodulator. 
 
The orphan G-protein coupled receptor 135 (GPCR135) or somatostatin- and 
angiotensin-like peptide receptor (SALPR) (Matsumoto et al., 2000; Liu et al 2003a; 
Liu et al., 2003b; Bathgate et al., 2006b Sutton et al., 2006), later reclassified as the 
relaxin family peptide 3 receptor (RXFP3) (Bathgate et al., 2006a), is the native 
receptor for relaxin-3. Like most GPCRs, RXFP3 has a seven transmembrane 
structure. Relaxin-3 can also bind and activate RXFP1 (Bathgate et al., 2006b) and 
RXFP4 (Liu et al., 2003a), two other members of the RXFP3 family.  RXFP1, the 
receptor for relaxin, is expressed widely in the peripheral tissues such as the ovaries 
and testes (Min and Sherwood, 1998; Filonzi et al., 2007), kidney (Samuel and 
Hewitson, 2009) and liver (Bennett et al., 2007). The relaxin/RXFP1 system is 
typically known for its role in growth and remodelling of reproductive tissues during 
pregnancy and parturition (Parry and Vodstrcil, 2007). 
  
In addition to peripheral expression, RXFP1 was also found to be expressed in the 
brain (Burazin et al., 2005; Ma et al., 2006) and have been implicated in maternal 
behaviour and even fear and memory regulation (Summerlee et al., 1984; Sunn et al., 
2002; Ma et al., 2005). Hence the activation of RXFP1 in the brain by endogenous 
relaxin-3 and the subsequent physiological effects cannot be disregarded. Most 
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findings however focused on the selectivity of relaxin-3 for RXFP3, suggesting that 
majority of relaxin-3 signalling is conferred by its binding to RXFP3. For instance, 
the distribution of relaxin-3 projections largely corresponds to the distribution of 
RXFP3 and not RXFP1. Besides, the behavioural effects in rats brought about by the 
use of a RXFP3 selective agonist mimicked that of studies using ICV infusions of 
relaxin-3 (Kuei et al., 2007; Sutton et al., 2009). RXFP4 on the other hand is the 
native receptor for insulin-like peptide 5 (INSL5) and its expression has been shown 
to be restricted to peripheral tissues such as the colon, thymus, placenta and thyroid in 
humans (Liu et al., 2005). In rats, RXFP4 is a pseudogene (Chen et al., 2005a) and 
thus will not be involved in any binding to relaxin-3.  
 
1.5 Connections of the nucleus incertus 
 
Two independent comprehensive studies on the connections of the NI have 
corroborated that the NI possibly exerts its actions through numerous projections to 
several parts of the brain, namely the pontine periventricular region, dorsal and 
ventral tegmental nuclei, dorsal raphe nucleus, roscephalic reticular nucleus, 
interpeduncular nucleus, lateral and posterior hypothalamus, supramammillary 
nucleus, medial septum, basolateral, cortical and medial nuclei of the amygdala, rostra 
zona incerta, supraoptic nucleus, mediadorsal nucleus of the thalamus, hippocampal 
formation , stria terminalis and anterior cingulated areas (Goto et al., 2001; Olucha-
Bordonau et al., 2003).  However, it is to be noted that connections from the NI to 
amygdala and suprachiasmatic nucleus were described by Olucha-Bordonau et al. 
(2003) but not discussed in Goto et al. (2001).  
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al., 2007). However, not all brain areas receiving relaxin-3 innervations are similar to 
the areas receiving NI projections possibly due to projections from the sparse relaxin-
3 neuron population outside the NI (pontine raphe nucleus, substantia nigra and 
anterior PAG) (Bathgate et al., 2002b; Tanaka et al., 2005; Ma et al., 2007; Gundlach 
et al. 2009). Notably, the amygdala, a brain nuclei thought to be implicated in fear, 
memory, emotional processing and anxiety, is innervated not only with projections 
from the NI, but these fibres have been shown to be relaxin-3 positive (Olucha-
Bordonau et al., 2003; Tanaka et al., 2005; Ma et al., 2007). Moreover, an elevated 
expression of RXFP3 in areas such as basomedial, central and medial nucleus of the 
amygdala seems to propose that the NI and its connections to the amygdala may have 
a role to play in the above mentioned behavioural functions (Sutton et al., 2005; Ma et 
al., 2007). 
 
1.6  Putative roles of the nucleus incertus 
 
1.6.1 Nucleus incertus and feeding 
 
Various lesion and electrical stimulation studies have established the role of the 
hypothalamus in the regulation of feeding and metabolism, particularly citing the 
lateral hypothalamus (LH) as an orexigenic centre. Stimulating the LH increases 
feeding behaviour, while the stimulation of the mediobasal hypothalamus, the satiety 
centre, suppresses feeding behaviour (Anand and Brobeck, 1951; Coons and Cruce, 
1968; Valenstein et al., 1968). The discovery of several neuropeptides further 
revealed the complex role of the hypothalamus in feeding behaviour. Neuropeptide Y 
(NPY), a peptide concentrated in the arcuate nucleus (ARC) elicits a feeding response 
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(Clark et al,. 1984; Stanley and Leibowitz 1984; Stanley and Leibowitz, 1985) and 
lowers metabolism (Billington et al., 1991; Walker and Romsos, 1993) when injected 
intracerebroventricularly. NPY neurons in the ARC also express Agouti-related 
peptide (AgRP), a potent and lasting appetite stimulator (Ollmann et al., 1997; Hagan 
et al., 2000). In contrast, two anorexigenic peptides: α-melanocyte stimulating 
hormone (α-MSH) and cocaine- and amphetamine-regulated transcript (CART) were 
expressed in a subpopulation of neurons in the ARC (Boston et al., 1997; Elias et al., 
2001) and act to decrease food intake and increase metabolism (Campfield et al., 
1995; Halaas et al., 1995; Pelleymounter et al., 1995; Stephens et al., 1995). The 
neurons in the ARC modulate feeding and metabolism via reciprocal networks with 
other regions of the hypothalamus, such as the paraventricular nucleus (PVN), 
ventromedial hypothalamus (VMH), LH and the dorsomedial hypothalamus (DMH) 
(Kalra et al., 1999; Elmquist, 2001).  
 
Reports of dense neuronal projections from the NI to the hypothalamus and reciprocal 
inputs from the hypothalamus to the NI suggested the idea of the NI being a central 
control centre regulating energy homeostasis (Goto et al., 2001).  Most studies to date 
have focused on the implications of relaxin-3 in feeding behavior. However, none of 
the studies have yet elucidated a definitive role of the NI in feeding responses. 
Unpublished data from our lab showed that the NI fires when a rat successfully enters 
the centre zone to feed in a novel environment suppression of feeding test, suggesting 
that the NI could play a direct role in eliciting a feeding behavior or responding to a 
feeding behavior. Relaxin-3 positive fibres were later found to project from the NI to 
the PVN and ARC, feeding centres known to influence energy balance (Sutton et al., 
2005). Relaxin-3 was first reported to be involved in feeding when human relaxin-3 
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(H3) injected either into the PVN or ICV in satiated rats resulted in a potent increase 
in food consumption  one hour post administration, both in the early light and dark 
phase. This was not seen when rats were injected with human relaxin-2 (H2) 
(McGowan et al., 2005). Unaltered expression of NPY and AgRP following H3 
administration suggested a new role for relaxin-3 in the acute regulation of appetite, 
actions which are likely to be caused by binding to RXFP3 in the hypothalamic PVN 
(McGowan et al., 2005).  
 
In the same period, an extensive mapping of relaxin-3 and RXFP3 in the rat brain 
revealed rather high densities of relaxin-3/RXFP3 in the ARC, PVN, DMH, VMH 
and LH (Tanaka et al., 2005; Ma et al., 2007). Following that study, acute intra-PVN 
administration of high doses of H3 (180-1620pmol) significantly increased post first 
hour food intake in satiated Wistar rats, while repeated intra-PVN H3 injection 
(180pmol/twice a day for seven days) increased cumulative food intake in rats 
(McGowan et al., 2006). In both groups, plasma thyroid stimulating hormone was 
greatly reduced while plasma leptin increased, suggesting that relaxin-3 may also 
control chronic food intake. Additional studies further demonstrated the orexigenic 
effects of relaxin-3. Acute local injection into regions such as the supraoptic nucleus 
(SON), ARC and anterior preoptic area (APOA) were shown to increase feeding 
(McGowan et al., 2007). Chronic infusions of H3 for 14 days not only resulted in an 
increase in food consumption and body weight gain, but also increased plasma leptin 
and insulin levels (Hida et al., 2006). Together this evidence suggested that the NI 
and/or relaxin-3/RXFP3 system could play an important role in appetite regulation, 
possibly implicating it as a target in eating disorders.  
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Although multiple functional studies have associated relaxin-3 with the control of 
feeding and metabolism in rats, the mechanism of action is still not known. Moreover, 
the populations of neurons in the hypothalamus that receive inputs from the NI or are 
directly influenced by relaxin-3 signaling have not been identified. Hence a more 
detailed characterization of the connections and how the NI itself and/or endogenous 
relaxin-3 can affect feeding behavior is necessary.  
 
1.6.2 Nucleus incertus and stress 
 
The extensive projections of the NI neurons places the NI in a strategic position to 
control multiple neural circuits involved in several physiological functions, ranging 
from influencing cognitive function to modulation of stress, anxiety, depression and 
regulation of appetite. A grossly summarized account of the classical stress response 
begins with the PVN receiving stressful sensory information, integrating this 
information and secreting CRF which in turn binds to CRF1 in the anterior pituitary to 
stimulate the release of adrenocorticotropic hormone (ACTH) into the blood stream. 
ACTH activates receptors in the adrenal gland, stimulating release of glucocorticoids 
that then alter blood pressure, heart rate, and other physiological processes in 
preparation for an appropriate response to the perceived threat. This characteristic 
response is described as activating the hypothalamic-pituitary-adrenal (HPA) axis. 
The NI was first suggested to playing a role in stress responses due to the high 
expression of CRF1 in rat (Potter et al., 1994; Bittencourt and Sawchenko, 2000; Van 
Pett et al., 2000), though the source of CRF activating the NI under stress is still not 
known. There is a possibility that CRF produced by the PVN of the hypothalamus or 
the central amygdala after a stressor (Swanson et al., 1983) can reach the NI via the 
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cerebrospinal fluid (CSF) or that it could be released by a neural input to the NI (Ryan 
et al., 2011).  
 
Several studies performed have identified a number of stressful conditions that 
activate the NI. As mentioned, an ICV injection of CRF activates the NI neurons as 
detected by the marked increase in Fos expression in the NI (Bittencourt and 
Sawchenko, 2000). Consistently, this increase in Fos expression following 1µg CRF 
infusion was later found to overlap with 65% of the relaxin-3 positive neurons in the 
NI (Tanaka et al., 2005). Rats that were restrained in plastic containers for 30 min 
displayed lower levels of c-Fos mRNA in the NI as compared to rats exposed to 10 
min of swim stress (Cullinan et al., 1995). In another study, rats that were restrained 
on their backs or in single plastic tubes for an hour showed robust increases in Fos-
like immunoreactivity in the NI (Senba et al., 1993). A combination of restraint and 
water immersion stress in rats led to a significant activation of the NI as seen by the 
strong induction of Fos, particularly in 60% of the relaxin-3 expressing neurons in the 
NI (Tanaka et al., 2005). Rats subjected to a repeated forced swim displayed similar 
increases in c-Fos in the NI neurons. Interestingly, these rats also showed robust 
increases in relaxin-3 expression in the NI, which was blocked upon pre-treatment 
with a CRF-R1 antagonist (Banerjee et al., 2010). Other stressors such as foot shock 
(Li and Sawchenko, 1998) and noxious stimuli like the lower limb pinch (Bullitt, 
1990; Senba et al., 1993) also activate the NI, albeit along with many other areas of 
the brain.  
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Further studies however are needed to elucidate the precise role the NI plays in 
responses to stress and whether relaxin-3 is indeed the neuropeptide involved in the 
regulation of the stress pathways. 
 
1.6.3 Nucleus incertus and arousal 
 
Behaviour activation has been linked to arousal and wakefulness (Saper et al., 2005), 
with “arousal” typically referring to the behaviour state of animals and humans 
involving increased alertness to sensory stimuli, amplified motor activity and 
increased emotional activity (Pfaff, 2006).  Levels of arousal correlate with the 24 h 
sleep-wake cycle but several other events, such as exposure to stress, can increase 
arousal levels. Initial tract-tracing experiments in rat showed strong reciprocal 
connections of the NI with the median raphe and interpenducular nucleus (IPN), 
predicting that the NI forms part of the behaviour state system, thus possibly 
influencing neural networks involved in modulating levels of arousal and functions 
related to exploratory behavior (Goto et al., 2001; Olucha-Bordonau et al., 2003). The 
NI is positioned close to the reticular formation, a region involved in generating the 
awake behavior state (Moruzzi and Magoun, 1949). Besides projecting to the 
mentioned nuclei known to play a role in modulating behavioural state, the NI also 
projects to the laterodorsal tegmental nucleus, dorsal raphe, substantia nigra pars 
compacta and lateral hypothalamus (LH) (Goto et al., 2001; Olucha-Bordonau et al., 
2003), which contains populations of neurons expressing orexin and melanin-
concentrating hormone (MCH) (Swanson, 2000; Jones, 2005; Smith et al., 2010). 
Relaxin-3 positive projections and robust levels of RXFP3 expression have also been 
discovered in these arousal related regions, suggesting that the NI may exert its 
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influence on the arousal networks via relaxin-3. Behaviour activation is closely 
controlled by the interaction of many ascending monoamine and peptide systems, 
such as seretonergic neurons in the raphe (Monti and Jantos, 2008). Furthermore, a 
recent study showed that 5-HT was able to negatively regulate the expression of 
relaxin-3 in the NI (Miyamoto et al., 2008) providing added evidence that the 
NI/relaxin-3 system may be involved in modulating ascending arousal networks. 
Besides, relaxin-3 mRNA expression in the NI was seen to vary over the 24 h cycle, 
peaking in the early dark phase, consistent with the idea that the NI neurons/relaxin-3 
are more utilized in the active (arousal) period of the light/dark cycle (Banerjee et al., 
2006; Ryan et al., 2011). 
 
A stress-induced insomnia study conducted recently, where rats were exposed to a 
psychological stressor (cage exchange) saw a marked increase in Fos expression in 
several arousal related brain regions including the NI (termed ‘nucleus O’) compared 
to the clean cage controls (Cano et al., 2008). Several other regions of the ‘arousal’ 
network, such as the locus coeruleus (LC) and the lateral preoptic area were also 
activated, adding to the idea that the NI may play a parallel role or regulate the 
currently known systems of behavior or arousal states. Interestingly, this study also 
showed the parallel activation of sleep-promoting areas, possibly as a result of 
ongoing homeostatic regulations (Cano et al., 2008). The authors also saw that 
inactivating the brain regions involved in arousal states led to the recovery of sleep 
states and the alteration of Fos expression patterns in the brain.  They proposed that 
inhibiting the arousal network, and not potentiating the sleep system, may be more 
effective in the treatment of insomnia (Cano et al., 2008). This implies that 
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modulating relaxin-3 levels in the stress-induced insomnia model may provide an idea 
on its role in arousal and also possibly target it as a treatment for insomnia.  
 
The extent of the interaction between the NI neurons and/or relaxin-3 with the various 
arousal systems remains unclear, thus further mapping and functional studies are 
required to elucidate whether the NI neurons directly signal to the populations of 
neurons involved in the arousal network or whether relaxin-3 is directly involved in 
the actions brought forth by the NI neurons, respectively. 
 
1.6.4 Nucleus incertus and septohippocampal theta rhythm 
 
Theta rhythm, a slow rhythmic brain electrical activity between 4-12Hz routinely 
recorded in the hippocampus, has been associated with the modulation of synaptic 
plasticity and encoding memory (Bland, 1986; Vertes et al., 2004; Vertes, 2005). 
There have been several debates about other brain areas generating theta rhythm but 
clear evidence showed that the medial septal projections to the hippocampus are 
particularly important in the generation of theta rhythm. Theta rhythm is generated via 
the synchronized firing of the GABAergic and cholinergic neurons of the medial 
septum and the vertical limb of the diagonal band (DBv), which terminates at the 
hippocampal GABAergic interneurons and principle cells, respectively (Vertes and 
Kocsis, 1997; Pedemonte et al., 1998). The initial speculations on the NI’s role in 
cognitive behavior are largely founded on the neuroanatomical track tracing studies 
that reported efferent and afferent projections between the NI and multiple forebrain 
structures that are involved in generating or modulating theta rhythm, including the 
hippocampus, medial septum and the supramammillary nucleus (Goto et al., 2001; 
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Olucha-Bordonau et al., 2003; Smith et al., 2010). The NI also projects and receives 
inputs from the medial raphe nucleus, whose activity is known to desynchronize theta 
rhythm (Kinney et al., 1995; Vertes and Kocsis, 1997; Viana Di Prisco et al., 2002). 
As mentioned earlier, the NI has been identified as the chief source of relaxin-3 in the 
mammalian brain(Bathgate et al., 2002) and it was later determined that some of the 
previously mentioned projections are contributed by relaxin-3 positive neurons from 
the NI (Tanaka et al., 2005; Ma et al., 2007). Furthermore, the presence of RXFP3 in 
these regions known to be contributing to cognition supports the hypothesis that the 
NI and possibly relaxin-3 may have a role in modulating hippocampal theta rhythm.  
 
Under basal conditions, the NI is almost devoid of spontaneous theta rhythmic 
activity (Nunez et al., 2006). It was proposed that the NI regulates theta rhythm via 
several pathways namely direct and medial septum mediated projections to the 
hippocampus, connections to the reticularis pontis oralis nucleus (RPO) and fibres to 
the median raphe nucleus and the hypothalamus. An electrophysiological study that 
was carried out suggested that the NI may act as a relay point between the RPO and 
the medial septum. Stimulating the RPO in anesthetized rats increased the firing 
activity of the NI neurons (Nunez et al., 2006). Nunez and colleagues also 
demonstrated that electrical stimulation of the NI could evoke hippocampal theta, 
while electrolytic lesion of the NI or pharmacological inactivation of the NI by 
muscimol abolished hippocampal theta evoked by RPO stimulation (Nunez et al., 
2006). Inhibitory projections of the nucleus incertus to the median raphe nucleus 
might enhance theta rhythm since the latter is involved in both desynchronizing theta 
rhythm and inhibiting behavioral activity (Jacobs et al., 1974; Srebro and Lorens, 
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1975; Wirtshafter and Asin, 1982; Asin and Fibiger, 1983; Kinney et al., 1995; Vertes 
and Kocsis, 1997; Viana Di Prisco et al., 2002). 
 
Furthermore, the arrangement of relaxin-3 immunopositive projections led to 
speculation that endogenous relaxin-3 may be involved in modulating theta rhythm 
and spatial memory. The basis for this is the fact that infusion of an RXFP3 agonist, 
R3/I5, into the RXFP3-rich medial septum increased hippocampal theta and enhanced 
fimbria evoked potentials in both hippocampus and medial septum, while infusion of 
an RXFP3 antagonist, R3(BΔ23-27)R/I5, blocked this effect in anaesthetized rats (Ma 
et al., 2009a). In freely moving rats, local infusion of R3/I5 into the MS promoted 
theta oscillations in their home cage, while a RXFP3 antagonist reduced hippocampal 
theta of rats in an enriched environment (Ma et al., 2009a). Hence it is likely that 
relaxin-3 may play a role in behaviour activation and memory. This was further 
supported by the poorer memory performance of rats in a spontaneous alternation task 
(SAT; related to navigation, exploratory behaviour and short term spatial memory) 
following the septal infusion of a RXFP3 antagonist (Ma et al., 2009a).  
 
The precise role of the NI, its projections and possibly relaxin-3 signalling, in the 
regulation of hippocampal theta rhythm, behaviour activation, sleep-wake modulation 
and memory encoding still requires further research.  
 
1.6.5 Nucleus incertus and anxiety 
 
While stress can result from any event that causes the feeling of fear, nervousness and 
possibly frustration, anxiety is marked by extreme fear (and avoidance) in response to 
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specific objects or situations but in the absence of true danger (Shin and Liberzon, 
2010). Given that extreme fear is a key component of anxiety disorders, it is not 
surprising that the initial hunt for the neurological network for anxiety disorders 
began with investigating the fear circuits in animals. Some of the main components of 
the fear circuitry include the amygdala, nucleus accumbens, hippocampus, thalamic 
nuclei, insular cortex and the infralimbic cortex (Shin and Liberzon, 2010). Research 
over the years have pointed out the role of the amygdala in fear acquisition and 
expression, hippocampus in contextual processing and the importance of the 
infralimbic cortex in extinction recall but the exact roles of many other regions in the 
fear circuitry are not yet firmly established. One of the major differences between fear 
and anxiety is the absence of true danger (unconditioned stimuli) in the latter, 
suggesting the possible involvement of other brain regions and a separate anxiety 
circuitry altogether.  
 
The amygdala however, seems to remain as an important region in the causation of 
underlying anxiety as several studies have reported hyperactivation of the amygdala 
in anxious situations, such as increased amygdala activation in response to trauma 
related images (Shin et al., 1997), sounds or smells related to combat (Liberzon et al., 
1999) and even fearful facial expressions (Bryant et al., 2008b) in patients with post-
traumatic stress disorder (PTSD). The amygdala was also described to be over-
activated in panic disorder, generalized anxiety disorder (GAD), obsessive-
compulsive disorder (OCD) and social phobia, particularly with the exposure of panic 
related words (van den Heuvel et al., 2005b), when anticipating aversive photographs 
(Monk et al., 2008), during public speaking (Tillfors et al., 2001) and/or the 
anticipation of public speaking (Lorberbaum et al., 2004). Studies disputing the 
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claims of a hyperactive amygdala have shown the opposite whereby the amygdala 
was not differently activated compared to controls or decreased activation in 
responses to a negative stimulus (Bremner et al., 1999a; Phan et al, 2006a) in patients 
with PTSD. Although several studies pinpointed the role of the amygdala in anxiety, 
neural circuits that control anxiety still remain unclear. 
 
Various studies sought to implicate the NI and relaxin-3 in physiological behavior. 
The initial claims of the NI’s role in anxiety originated from the results of the 
retrograde tracing studies in rats that revealed projections of the NI into the putative 
regions of anxiety, namely the amygdala, median raphe, hippocampus and thalamus 
(Goto et al., 2001, Olucha-Bordonau et al., 2003). Not only are these projections 
found to be relaxin-3 positive, the robust expression of RXFP3 in these putative 
targets of anxiety suggested that the NI may exert its control in anxiety via relaxin-3 
(Sutton et al., 2004; Tanaka et al., 2005; Ma et al., 2007).  Electrical lesions of the NI 
caused a significantly slower extinction of conditioned freezing response in rats 
compared to the sham and control groups (Pereira et al., 2013), a telltale indication of 
heightened anxiety due to the loss of the NI neurons. The same authors also 
demonstrated the loss of relaxin-3 positive fibers in the amygdala, bed nucleus of stria 
terminalis (BNST) and the medial septum, further implicating the role of relaxin-3 in 
the modulation of anxiety.  In a separate study, a single ICV administration of human 
relaxin-3 increased the amount of time rats spent in the open arms and open arm 
exploration compared to a saline treated group (Nakazawa et al., 2013). Likewise, a 
single ICV infusion of human relaxin-3 significantly decreased defensive burying 
behavior of rats in a shock-probe burying test, an indication of the anxiolytic effect of 
relaxin-3 (Nakazawa et al., 2013). A study carried out with relaxin-3 KO mice 
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presented no differences in social interaction, fear conditioning, open field and 
light/dark tests compared to wild-type mice (Watanabe et al., 2011). Unexpectedly, in 
an elevated plus maze test, relaxin-3 KO mice displayed increased tendencies to enter 
the open arms (Watanabe et al., 2011), an effect opposite from that seen in rat studies. 
 
As mentioned earlier, the NI in rats predominantly expresses CRF1 (Potter et al., 
1994; Bittencourt and Sawchenko, 2000; Van Pett et al., 2000). In contrast, the mouse 
NI has a rather low expression of CRF1 but high expression of corticotropin-releasing 
factor binding protein (CRF-BP, binds and neutralizes the biological activity of CRF) 
(Lein et al., 2007).  The dissimilarities in the expression of CRF1 and CRF-BP in rats 
and mice might result in the differential activation of the NI between the two species 
and thus a different behavioural outcome following neurogenic stressors. 
 
Furthermore, due to the unusual receptor expression in the NI, it is also worth 
investigating, non-relaxin-3 effects on anxiety behavior. The NI expresses CRF1, 
GABAA and 5HT1A (Potter et al. 1994; Bittencourt and Sawchenko 2000; Tanaka et 
al. 2005; Ma at el., 2007; Miyamoto et al., 2008). Research had shown that 
modulation of CRF1 receptors can influence anxiety states of rodents. Thus, the rich 
expression of CRF1 in the NI is an added indication of the NI’s putative role in 
anxiety. Combined with the restricted expression of relaxin-3 to the NI, it is possible 
that the interaction of the relaxin-3 circuits and CRF1 receptor systems contributes to 
the aetiology of anxiety. Moreover, the NI expresses 5HT1A and GABAA receptors 
which are well documented targets for many of the current anxiolytic drugs. Even 
though some studies have predicted the putative role of the NI and relaxin-3 in 
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anxiety behaviors, the exact way the NI exerts its control remains a topic to be 
investigated.  
 
1.7 Hypothesis and aims 
 
The NI has been implicated in the control of multiple neural networks involved in 
numerous physiological functions, ranging from the regulation of feeding behavior to 
modulation of stress and arousal, influencing theta and controlling theta. In addition, 
these projections were found to be relaxin-3 positive. The widespread mapping of 
RXFP3 expression in the same brain areas contributing to the mentioned 
physiological roles coupled with the exclusive expression of relaxin-3 in the NI, 
suggests that the NI and possibly the relaxin-3/RXFP3 system is involved. ICV 
infusions of relaxin-3 increased feeding in satiated rats and produces an anxiolytic 
effect in rats in an elevated plus maze, suggesting that relaxin-3 can act on multiple 
networks in the brain. Research on the NI has always pinpointed relaxin-3 as the main 
player in exerting its functions, yet neglecting the possible actions of the other 
neurotransmitters that are present. Hence, this thesis is based on the broad hypothesis 
that the NI, because of its extensive projections in the brain, can modulate feeding and 
anxiety responses in rats. 
 
While some of the hypothesized functions of the NI are speculations from the vast 
mapping results, most of the experimental evidence to date stem from studies using 
relaxin-3 related peptides, studies of neural activation based on behavioural activity, 
electrical stimulation or infusion of CRF. To further investigate the role of the NI in 
appetite and anxiety regulation, this thesis first aims to establish a method using the 
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CRF-saporin conjugate to selectively target and ablate the NI neurons in rats. The loss 
of the CRF1 positive neurons in the NI will be validated with reverse transcriptase 
polymerase chain reaction (RT-PCR) analysis, real-time RT-PCR, western blotting 
and immunofluorescence staining. The effect of this loss of NI neurons on feeding 
and anxiety behaviour in rats will then be examined in a number of behaviour setups, 
namely food intake, choice of feed, fear conditioning, open field, elevated plus maze, 
novel environment suppression of feeding and the light dark box.  
 
Clearly, relaxin-3 expression is highly restricted in the NI, therefore, this project also 
aims to question if relaxin-3 is indeed the neuropeptide orchestrating the actions of 
the NI in regulating anxiety. Firstly, the loss of relaxin-3 expressing cells after CRF-
saporin injection will be confirmed. Given the relaxin-3 positive connections of the 
NI to the amygdala, I will also like to find out whether infusion of human relaxin-3 
into the central amygdala after the lesion will reverse some of the behavioural deficits 
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2. Establishing a method to lesion CRF1-expressing cells in the nucleus 
incertus  
 
2.1  Introduction 
 
Ribosome-inactivating proteins (RIP), characteristic of several bacteria and plant 
toxins, inhibit protein synthesis by enzymatically damaging ribosomes (Stirpe et al., 
1983). Type I RIPs are single chain proteins while type II RIPs consist of an 
enzymatic A chain and a B chain with lectin activity. Type II RIPs binds to galactose 
residues present on cell membranes, causing cells to agglutinate. This binding also 
allows the A chain to enter the cells, ceasing protein synthesis by causing irreversible 
damage to the ribosomes (Wiley, 1992; Contestabile and Stirpe, 1993). Amongst 
them, ricin and abrin, the first identified RIPs, are extremely potent and highly fatal 
when exposed. Type I RIPs on the other hand are devoid of a binding chain, thus not 
as efficiently internalized. However, if they have the means to enter the cell via viral 
envelopes or even proteins that are capable of binding to cell receptors, they can be 
rendered as toxic as type II RIPs. By harnessing the toxic properties of these RIPs, 
immunotoxins generated from the conjugation of specific antibodies to the toxin are 
gaining interest as innovative therapeutic agents (Ramakrishnan and Houston, 1984; 
Seon, 1984; Sapra and Shor, 2013; Stratford et al., 2013) 
 
Like all type I RIPs, saporin, a monomeric protein purified from the seeds of 
Saponaria officinalis, can inhibit protein synthesis in cell-free systems but has less 
effect on intact cells (Stirpe et al., 1983). It exerts its actions via the specific 
depurination of eukaryotic ribosomes (Santanche et al., 1997). Due to its toxicity, 
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saporin proved useful in the synthesis of several immnuotoxins. Thorpe’s study 
demonstrated that the toxic effect of anti-thy 1.1 (OX7) conjugated saporin was 
specific to thy 1.1-expressing cell lines but not to thy 1.2-expressing lymphoma cells 
(Thorpe et al., 1985). On the other hand, the well-known ricin A-chain coupled to 
OX7 antibody was seemingly less effective as an antitumor agent in vivo compared to 
OX7-saporin (Thorpe et al., 1985). Interestingly, saporin is extremely resistant to 
denaturation by urea or guanidine. Unfolding of this protein is minimal even at high 
temperatures and harsh UV conditions (Santanche et al., 1997). The extraordinary 
resistance of saporin to denaturation and proteolysis makes this protein an excellent 
candidate for biotechnological research.  
 
A strategy to achieve potent and selective lesioning of target brain structures to study 
their functions has been to utilize cell-surface protein binding peptides or antibodies 
conjugated with saporin (Heckers et al., 1994; Maciejewski-Lenoir et al., 2000; Botly 
et al., 2009; Kaur et al., 2009; Hummel et al., 2010). Selectivity is achieved because 
saporin is only toxic to the cells when internalized by the corresponding receptor. 
Saporin had been used with much success in both rats and mice. A newer subtype of 
the murine p75-saporin was shown to produce a selective loss of cholinergic neurons 
in the basal forebrain of adult mice (Nag et al., 2009). Selective destruction of NPY-
expressing neurons by the agonist driven receptor internalization of NPY-saporin 
have been used as a tool to study the NPY circuitry involved in feeding behaviours. 
The specific loss of NPY-expressing neurons in the ARC and the basomedial 
hypothalamus has been shown to induce hyperphagia and obesity in lesioned rats (Li 
et al., 2008). Injection of the same toxin into the central amygdala of mice produced a 
selective reduction of NPY1 receptor expressing cells and was associated with 
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increased anxiety-like behaviour. The corticotropin releasing factor (CRF)-saporin 
conjugate toxin, used in the present study is expected to selectively ablate CRF1 
expressing cells (Chance et al., 2006; Pascual and Heinrich, 2007; Turner et al al., 
2007; Hummel et al., 2010). On the premise that relaxin-3 expressing neurons in the 
NI predominantly co-express CRF1 receptors (Tanaka et al., 2005), the present 
investigation attempted to establish a method for ablation of the CRF1-expressing 
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2.2  Materials and Methods 
 
2.2.1 Animals and surgery 
 
Male Sprague-Dawley (SD) rats (270-290 g) procured from the Centre for Animal 
Resources (CARE), National University of Singapore were maintained under standard 
housing conditions (21±2 oC, 12hr light-dark cycle and ad libitum food and water). A 
total of 35 SD rats were used. All experimental procedures were approved by the 
Institutional Animal Care and Use Committee (IACUC), National University of 
Singapore, and were in accordance with the guidelines of the National Advisory 
Committee for Laboratory Animal Research (NACLAR), Singapore, and the Guide 
for the Care and Use of Laboratory Animals, National Research Council of the 
National Academies, USA. Rats were acclimatized for five days upon arrival at the 
animal holding unit before any surgical procedures were carried out. Rats were first 
anaesthetized with an intraperitoneal (IP) injection of a ketamine (75 mg/kg) and 
xylazine (10 mg/kg) cocktail before being placed in a stereotaxic frame. The surgical 
site was shaved and thoroughly disinfected with iodine solution and ethanol. After an 
incision was made, the skull was cleaned and burr holes were drilled on the skull at 
the coordinate corresponding to the NI (AP: 9.7 mm and ML:0-0.1 mm) (Paxinos and 
Watsons, 2007) calculated from the bregma. Bilateral injections of 0.2 µl/site made 
7.5 mm ventral to the surface of the skull delivered 86 ng/site of CRF-saporin or 
unconjugated saporin (Advanced targeting Systems, USA) over five minutes. The 
treatment was done in a single blind manner. The needle was left in place for 5 more 
minutes before withdrawal. The burr hole was then packed with a gelatine hemostat 
(B Braun, Melsungen, Germany) to control bleeding. The scalp was sutured and 
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cleaned with iodine solution to prevent any infection. Rats were given a subcutaneous 
injection of caprofen (5mg/kg) and enrofloxacin (10mg/kg) for the first five days after 
the surgery and allowed to rehabilitate for 14 days before any experiments were 
carried out. All rats were housed individually to prevent injury caused by fighting or 
picking on each other’s sutures. 
 
2.2.2 Preparation of mouse anti-relaxin-3 antibody 
 
To prepare the mouse anti-relaxin-3 antibody, HK4-144-10 cells (Kizawa et al., 2003) 
were obtained from the International Patent Organism Depository (IPOD), National 
Institute of Advanced Industrial Science and Technology (AIST), Japan, and first 
cultured in an antibiotic free GIT medium (Wako Pure Chemicals Industries Ltd, 
Japan). The recovered hybridoma cells were then allowed to grow vigorously to log 
phase. The viability of the cells (>90%) was determined before harvesting and 
freezing for ascites production. Mice were first inoculated intraperitoneally with 
monoclonal antibody–producing hybridoma cells; thereafter, the ascites fluid was 
collected and purified (1st Base, Singapore, ProSci Incorporated, USA). An extra 
purification step was carried out whereby the ascites fluid was first diluted with an 
equal volume of binding buffer (1.5M glycine, pH9.0, 3.5M sodium chloride and 
0.05% sodium azide) and allowed to bind to Protein A agarose (Thermo Scientific, 
USA) for 48 hours at 4oC. The bound antibodies were then eluded with 0.1M citrate 
buffer containing 0.05% sodium azide. The eluate was concentrated in a centrifugal 
filter unit (Millipore, USA), washed with sterile phosphate buffered saline (PBS) and 
stored as a 1 mg/ml stock containing 0.05% sodium azide and 0.1% glycerol at -20oC.  
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2.2.3 Perfusion fixation and fresh tissue harvest 
 
Rats were anesthetized with an overdose of pentobarbital (150mg/kg) prior to 
transcardial perfusion with 0.9% saline, followed by 4% paraformaldehyde in 0.1M 
phosphate buffer (pH 7.4). The brain was removed immediately, post-fixed in the 
same fixative overnight at 4°C and then saturated with 30% sucrose in phosphate 
buffered saline (PBS). Free floating sections (30µm) were obtained with a vibratome 
(Leica Microsystems, Germany) and stored in a cryoprotectant (0.05M phosphate 
buffer pH7.2, 0.9% sodium chloride, 30% sucrose, 0.1% polyvinylpyrrolidone, 30% 
ethylene glycol) solution (Watsons, 1984) at -20oC.  
 
For reverse transcriptase polymerase chain reaction (RT-PCR) amplification and 
western blot analysis, rat brains were removed immediately following anaesthesia 
overdose and a 1000µm section was collected using a rat brain matrix (Roboz 
Surgical, USA). The position of the NI was confirmed under a light microscope 
before being dissected with a Harris Uni-CoreTM 1 mm micro-punch (Ted Pella Inc, 
USA) for further analysis.  
 
2.2.4 RNA extraction and real-time Reverse Transcriptase PCR (RT-PCR) 
 
Total RNA was extracted, treated with DNaseI (DNase I recombinant, RNase-free; 
Roche Diagnostic GmbH, Germany) and purified according to the manufacturer’s 
instructions for Purelink Mini Total RNA Purification kit (Invitrogen, USA) from the 
harvest NI tissues. The amount of RNA was quantified with a NanoDrop UV-Vis 
spectrophotometer (Thermo Scientific, USA). Approximately 1µg of total RNA was 
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reverse transcribed with oligo(dT) primers using ImProm-IITM Reverse Transcription 
system (Promega, USA). The PCR reaction for sham- (n=4) and NI-lesioned (n=4) 
rats was performed using the following sets of primers: 
 
Table 2.1 – RT-PCR primer sequence and amplicon size of CRF1, relaxin-3, GAD65, 
TPH2 and β-actin 
 
Gene Forward Primer Reverse Primer Amplicon 
size 
CRF1 5’-ACC GAC CGT CTG CGC 
AAG TG-3’ 






5’-CTG CTG CTG GCT TCC TGG 
GCT CTC CTC GGG GCT CT-3’ 
5’-TCG CTG GCC AGG TGG 
TCT GTA TTG GCT TCT CCA 
TCA-3’ 
218bp 
GAD65 5’-GAA CAG CGA GAG CCT 
GGT-3’ 
5’-CTC TTG AAG AAG CTC 
ATT GG-3’ 
362bp 
TPH2 5’-TAA ATA CTG GGC CAG 
GAG AGG-3’ 





5’-ATC CTG AAA GAC CTC TAT 
GC-3’ 




The primers were designed with an online primer designing tool, primer-BLAST. The 
PCR reactions were conducted at 94oC for 5 min, 30 cycles of 94oC for 30 sec, 60oC-
65oC for 1 min, 72oC for 1 min followed by 10 min at 72oC. The PCR products were 
then separated in 1.5% agarose gel, stained with ethidium bromide, and then 
visualized under UV irradiation. 
 
Real-time RT-PCR amplification on a separate group of sham- (n=4) and NI-lesioned 
(n=4) was carried out using the ViiA 7 Real-time RT-PCR system (Applied 
Biosystems, USA) with SYBR green PCR master mix (Applied Biosystems, USA) 
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Table 2.2 – Real-time RT-PCR primer sequence and amplicon size of CRF1, relaxin-
3, GAD65, TPH2 and β-actin 
 
Gene Forward Primer Reverse Primer Amplicon 
size 
CRF1 5’-ACG ACA AAC AAT GGC 
TAC CG -3’ 
5’-GCA GTG ACC CAGGTA 




5’-CCC TAT GGG GTG AAG CTC 
TG -3’ 
5’-CCA GGT GGT CTG TAT 
TGG CT -3’ 
148bp 
GAD65 5’-GGG GTG GAG GGT TAC 
TGA TG -3’ 
5’-ACC CAT CAT CTT GTG 
GGG AT -3’ 
98bp 
TPH2 5’-GCC TTT GCA AGC AAG 
AAG GT -3’ 
5’-CGC CTT GTC AGA AAG 




5’-ATC CTG AAA GAC CTC TAT 
GC-3’ 




The primers were designed with an online primer designing tool, primer-BLAST and 
checked for primer specificity against the rattus norvegicus Refseq mRNA database. 
β-actin was used as an internal control. The PCR conditions were: an initial 
incubation of 50°C for 2 min and 95°C for 10 min followed by 40 cycles of 95°C for 
15 s and 59°C for 1 min. 
 
2.2.5 Western blot 
 
Fresh NI tissue was dissected and lysed with radioimmunoprecipitation assay (RIPA) 
buffer. The total protein concentration was determined using a Pierce bicinchoninic 
acid assay (BCA) kit (Pierce Biotechnology, USA). 100µg of protein was separated 
by 12% sodium dodecyl sulphate SDS-PAGE for about 1.5 hours and then electro-
transferred onto a nitrocellulose membrane (Biorad, USA) at 100mA for two hours. 
The membranes subsequently blocked with 5% skim milk in Tris-buffered 
saline/Tween 20 (TBST) for an hour in room temperature followed by incubation with 
a goat anti-CRF1/2 (1:1000, Santa Cruz, USA) to determine CRF1 protein levels, 
mouse anti-relaxin-3 (1:2500) to measure relaxin-3 protein levels, rabbit anti-GAD65 
(1:1000, Millipore, USA) to check for GAD65 expression levels after the lesion, 
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rabbit anti-TPH2 (1:1000, Chemicon, USA) to verify the specificity of the lesion and 
anti-β-actin (1:10 000; Sigma-Aldrich) overnight at 4°C.  The blot was then washed 
five times in TBST for five minutes each time and incubated with a peroxidase-
conjugated anti-goat, anti-mouse or anti-rabbit IgG (1:5000; Pierce Biotechnology) 
for an hour at room temperature with agitation. Detection of the protein bands were 
done by incubating the peroxidase substrate SuperSignal West Femto (Pierce 
Biotechnology) with the membranes for five minutes before exposing it on an X-ray 
film.  
 
2.2.6 Immunofluorescence histochemistry 
 
Perfused sections were hydrated in PBS before being subjected to permeabilization 
with 0.3% Triton X-100/PBS solution. Blocking was carried out in a 5% donkey or 
goat serum/0.3% Triton X-100/PBS solution. Sections were immunostained with a 
primary antibody solution which contained goat anti-CRF RI/II antibody (1:1000, 
Santa Cruz), mouse anti-relaxin-3 antibody (1:1000) and rabbit anti-tryptophan 
hydroxylase 2 (TPH2) antibody (1:1000, Chemicon). Stained sections were 
subsequently visualized with donkey anti-goat Alexa Fluor 555 (1:400), donkey anti-
mouse Alexa Fluor 488 (1:400) or goat anti-rabbit Alexa Fluor 488 (1:400) secondary 
antibodies, after which sections were washed and mounted using Prolong Antifade 
with DAPI (Invitrogen) and viewed with a fluorescence microscope. For sections 
stained with anti-CRF RI/II, positive staining of the CRF1 expressing neurons in the 
locus coeruleus was first confirmed before images of the NI were analysed. 
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2.2.7 Analysis and statistics 
 
RT-PCR gel and western blot images were tabulated in Excel and then analysed with 
an image processing and analysis in Java (ImageJ) program. The density of each band 
was measured and normalized to its corresponding β-actin band (RT-PCR: n=4 each 
for sham and NI-lesioned; real-time RT-PCR: n=4 each for sham- and NI-lesioned, 
western blot: n=3 for sham-lesioned and n=4 for NI-lesioned).  The densitometry data 
was statistically analysed with unpaired t tests (GraphPad, San Diego, USA) 
comparing sham-lesioned and NI-lesioned groups for each protein. Generation of 
graphs used in figures was conducted with the GraphPad Prism software. P<0.05 was 
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2.3  Results 
 
2.3.1 Effect of CRF-saporin on CRF1, relaxin-3 and GAD65 mRNA expression 
 
To determine whether CRF-saporin affects CRF1 expressing cells, an RT-PCR 
analysis was conducted on the NI tissues of rats that received blank saporin or CRF-
saporin. Results indicated that rats which received the infusion of CRF-saporin saw a 
substantial decrease in the expression of CRF1 mRNA as compared to the sham-
lesioned group, p=0.0324 (Figure 2.1).  There was also a corresponding decline in the 
expression of relaxin-3 and GAD65, about 70% (p=0.0003) and 60% (p=0.0027) loss 
respectively (Figure 2.1B) for the NI-lesioned rats as compared to the sham-lesioned 
rats. TPH2 expression was unaltered in both the sham- and NI-lesioned groups as seen 
in the densitometric evaluation of the gel (Figure 2.1B).  
 
A real-time PCR analysis also showed that the CRF1 mRNA levels in NI-lesioned rats 
was 0.004-fold as compared to sham lesioned rats. Relaxin-3 and GAD65 mRNA 
expression in NI-lesioned rats 0.02- and 0.07 fold relative to the sham-lesioned 
controls while TPH2 mRNA levels was unchanged in both sham- and NI-lesioned rats 
(Figure 2.1C). 
 
2.3.2 Decreased CRF1, relaxin-3 and GAD65 protein expression 
 
To corroborate the data, protein expression of CRF1 receptor was also assessed by 
western blotting. Likewise, CRF1 expression was considerably reduced in the NI-
lesioned rats as compared to the sham-lesioned group (p=0.0004) (Figure 2.2A). A 
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consistent decrease in the levels of pro-relaxin-3 was observed in the group of rats 
which received CRF-saporin infusions (p=0.0086) (Figure 2.2A). The same set of 
samples was also checked for GAD65 and TPH2 protein levels. A resulting decrease 
in the expression of GAD65 (p=0.0049) was also observed in the NI-lesioned rats, 
while TPH2 expression levels were not affected by the infusion of CRF-saporin 
(Figure 2.2A). Densitometry analysis of the western blot demonstrated a statistically 
significant reduction in CRF1 (approximately 50%) expression. There was also 60% 
decrease in pro-relaxin-3 expression and approximately 65% loss in GAD65 protein 
levels (Figure 2.2B). 
 
2.3.3 Loss of CRF1 and relaxin-3 expressing cells 
 
Further confirmation of the lesion was carried out by immunofluorescence labeling 
with anti-CRF1, relaxin-3 and TPH2 antibodies. The results verified the loss of CRF1 
receptor positive cells in the NI of the NI-lesioned rats when compared with the sham-
lesioned rats (Figure 2.3A-B). Similarly, the images also depict the loss of relaxin-3 
expressing cells in the NI-lesioned rats (Figure 2.3D). To ascertain the specificity of 
CRF-saporin, examination of TPH2 expression was carried out in the sham- and NI-
lesioned rats. The staining results revealed that TPH2 positive cells lined the midline 
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Figure 2.2. Protein expression of CRF1, pro relaxin-3, GAD65 and TPH2 after 
CRF-saporin induced ablation of NI neurons. Sham lesions were produced by 
injection of blank saporin (n=3) while lesions of the NI (n=4) were produced by 
injection of CRF-saporin. 100µg of total protein extracted were separated and 
visualized on a SDS-PAGE gel. (A) Representative western blot bands showing the 
decreased expression of CRF1, Pro-RLX3 and GAD65 in the NI-lesioned rats. Β-actin 
was used as a control. Comparable expression of TPH2 indicated that CRF-SAP 
targeted only the CRF1 positive cells. (B) Densitometry analysis of the blot where the 
band densities were normalized to their corresponding β-actin bands. **p<0.01, 
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2.4  Discussion 
 
Here, a method to selectively ablate the CRF1-expressing NI neurons was described. 
Of all the 35 rats used for the lesioning procedure in this chapter, lesioning neither 
caused mortality nor alteration in feed and water consumption, which is in agreement 
with the current findings on relaxin-3 knockout mice (Smith et al., 2009; Watanabe et 
al., 2011; Smith et al., 2012). The results show that infusion of 172ng of CRF-saporin 
was sufficient to bring about a significant loss in CRF1 expressing cells in the NI. This 
was in accordance to the findings by Pascual’s group where 1-2µg of CRF-saporin 
injected ICV resulted in a significant loss in CRF1 positive cells in the fundus of the 
striatum (FS) and lateral septum (LS) (Pascual and Heinrich, 2007).  Similarly, a 
single 2µg ICV infusion of CRF-saporin in seizure susceptible El mice also led a 
substantial loss in cells expressing CRF1 in the basolateral amygdala (Turner et al., 
2007), suggesting that CRF-saporin was able to target and permanently silent CRF1 
expressing cells in the brain. Unconjugated saporin did not affect expression of CRF1 
as seen in the sham lesion rat groups, which was in agreement with the observation 
that saporin protein alone does not bind to any receptors and cannot be internalized by 
cells (Stirpe, 1982; Maciejewski-Lenoir et al., 2000).  
 
Previous evidences have shown that all relaxin-3 expressing cells in the NI co-express 
CRF1 and can be activated by ICV administration of CRF (Tanaka et al., 2005; 
Banerjee et al., 2010), thus this study also inspected the expression of relaxin-3 in the 
NI cells after CRF-saporin targeted lesion. The consistent decrease in relaxin-3 
expression corresponded to the findings that the NI cells express both CRF1 and 
relaxin-3, making it a possible tool in the study of relaxin-3 circuitry in the brain. A 
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recent study by Ma and her colleagues established the correlation between the firing 
of the NI neurons and their responses to CRF to relaxin-3 occurrence in the brain. The 
data disclosed that 90% of the NI neurons that were activated by ICV CRF infusion 
were relaxin-3 positive (Ma et al., 2013). This supported the application of CRF-
saporin as a tool not only to destroy CRF1 expressing neurons but also to selectively 
ablate the relaxin-3 expressing NI neurons. Since the NI is the chief source of relaxin-
3 in the brain (Burazin et al., 2002), it is inevitable that most investigations on the 
functions of the NI arise from the study of the relaxin-3 circuitry. However, the other 
peptides present in the NI cannot be neglected. This lesion model also demonstrated 
the compelling decrease in GAD65 expression, a known indicator of GABAergic 
neurons. Relaxin-3 neurons in the NI were known to co-express GAD65 (Ma et al., 
2007), an important indication that the neurotransmission from the NI is inhibitory. 
Thus the resulting loss in GAD65 expression reinforced the findings that NI neurons 
are GABAergic and also provides an additional verification that CRF-saporin is toxic 
to the CRF1-expressing NI neurons. 
 
The present method did not completely lesion the NI  but it was interesting to note 
that the concentration and volume of the toxin employed was sufficient to cause a 
characteristic behavioral anomaly (discussed in Chapter 3), possibly a consequence of 
an overall reduction in CRF1 and relaxin-3 expressing cells. It might be possible to 
produce lesions of the NI to a greater extent by injecting greater volumes or 
concentrations of CRF-saporin. However, CRF1 receptors are also present in other 
nearby structures such as the locus coeruleus (LC) and there is a risk that the 
selectivity of the lesion will be compromised. Moreover, the NI spans only around 
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700 microns in the anterior-posterior aspect and hence multiple injections can cause 
physical injury to the cells, which is undesired. 
 
A recent paper reported that electrolytic lesioning of the nucleus incertus results in   
the distinct loss of NI neurons as indicated by the reduction of calretinin 
immunoreactivity (Pereira et al., 2013). However, electrolytic lesions lack cellular 
selectivity and are likely to damage fibres of passage projecting to and from the NI. In 
this chapter, it was demonstrated that CRF-saporin selectively targets and ablates 
CRF1 positive cells while leaving other cells without the receptor unharmed, 
signifying the specificity of this toxin. The NI and pontine raphe nucleus are both 
found caudal to the 5HT-neurons populated dorsal raphe nucleus. It was previously 
reported that the distribution of 5HT-positive neurones was found in the region dorsal 
to the NI and that the 5HT-immunoreactive fibres enter into the NI and intermingled 
but did not overlap with the relaxin-3-expressing (Tanaka et al., 2005; Miyamoto et 
al., 2008). In this lesion model, expression of TPH2 was unaffected by CRF-saporin 
infusions and TPH2 cells lining the midline of the NI were intact even at 14 days after 
the procedure. This finding reiterates the specificity of CRF-saporin in targeting only 
the cells that express the CRF1 receptor. Besides, earlier studies described that 
relaxin-3 expression was negatively influenced by serotonergic activity via the 5HT1A 
receptors (Miyamoto et al., 2008), emphasizing the importance of retaining these 
TPH2 expressing cells.  There have not been much data on the usage and specificity 
of CRF-saporin, but RT-PCR analysis of hypothalamus samples of rats which 
received an ICV injection of CRF-saporin observed the unharmed expression of CRF2 
receptors, implying that CRF-saporin was more specific to CRF1 expressing cells 
(Chance et al., 2006). Maciejewski-Lenoir and colleagues also showed that CRF-
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saporin had a greater binding affinity to CRF1 as compared to CRF2α receptors 
(Maciejewski-Lenoir et al., 2000). Other conjugated saporin studies however can 
somewhat support the specificity and selectivity of CRF-saporin. In a study using the 
rat 192 IgG-saporin cholinergic immunotoxin, the authors saw the distinct loss of 
cholinergic neurons while the parvalbumin expressing neurons were spared (Heckers 
et al., 1994; Botly et al., 2009), indicating that the binding affinities to different 
receptors can differ depending on the conjugated peptide used. Also it emphasizes that 
for saporin to exert its toxic functions, it must be conjugated to a protein or peptide 
that can be recognized and taken up by the cells expressing the specific receptors.  
 
As previously mentioned, because of the distinct presence of relaxin-3 in the NI, 
numerous studies have used human relaxin-3, relaxin-3 specific agonists and 
antagonists, relaxin-3 knockout mouse models and miRNA targeted silencing of 
relaxin-3 in NI neurons to study the various postulated functions of the NI (McGowan 
et al., 2006; Ma et al., 2009; Smith et al., 2009; Watanabe et al., 2011; Callander et 
al., 2012; Smith et al., 2012), often, equating the function of the NI to that of relaxin-
3. Unlike a relaxin-3 knockout mouse model, the” acute” loss of CRF1 positive NI 
neurons in this lesion model may resolve some of the confounding behavioural 
responses brought about by compensatory mechanisms. Furthermore, besides co-
expressing GAD65 and perhaps co-releasing GABA, all the relaxin-3 neurons in the 
NI also co-express CRF1. 65% of the relaxin-3 positive neurons in the NI displayed 
elevated levels of nuclear Fos after an icv injection of 1 µg of CRF (Tanaka et al., 
2005), suggesting that there is functional interaction among the signaling systems. 
The present method to perturb the NI neurons and also the relaxin-3 system using 
CRF-saporin is expected to open an additional approach for research to understand the 
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relevance of the NI/relaxin-3 system together with possible GABAergic interventions 
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In the previous chapter, it was shown that CRF-saporin targeted lesioning of the 
CRF1-expressing neurons in NI of rats resulted in a specific and significant reduction 
in CRF1-expressing neurons, protein and mRNA levels. Collectively, levels of 
relaxin-3 and GAD65 also decreased. However, whether this loss of the CRF1 positive 
NI cells affects behaviour of rats still requires further investigation. This chapter 
explores the behavior of sham- and NI lesioned rats in feeding and anxiety-like 
behaviour. 
 
In view of relaxin-3 being associated with increased body weights and food 
consumption (McGowan et al., 2005; Hida et al., 2006; McGowan et al., 2006; 
McGowan et al., 2007), the NI quickly became an experimental target for intervention 
in eating disorders. Therefore it is imperative to better understand the function of the 
NI, not only relaxin-3 in appetite regulation. Food intake behaviour does not only 
involve hunger and satiety but also acquired preference for certain foods. Some foods 
can be more rewarding than others and may be overconsumed even in a sated state. 
High fat and sugar foods have been linked to escalating rates of overeating and 
obesity, where consumption of palatable foods can produce a rewarding effect and 
reinforce subsequent behaviours.  Although the idea of “food addiction” has not been 
proven, it has been liken to an effect similar to drug addiction where the brain reward 
circuitry gets altered by overconsumption of palatable food. Due to the anatomical 
projections of the NI and its ability to interact with the CRF1 system (Banerjee et al., 
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2010; Ma et al., 2013) and numerous other brain regions such as the amygdala and 
hippocampus, it is possible that the capacity of the NI to regulate feeding may also be 
influenced by other factors such as stress, anxiety and rewards. Food preference tests 
or variations of them, as the name terms, had been used in studies to evaluate diet 
selection between obese and lean rats (Greenberg and Weatherford, 1990), determine 
preference for sucrose of rats after being subjected to chronic stress (Lucca et al., 
2008; Hong et al., 2012) and even the rat’s response to familiar foods after drug 
treatment (Cooper, 1980). Hence, in this chapter, besides documenting the weight and 
food intake of the NI-lesioned rats, the preference or the lack of- for a high sugar diet 
was also investigated to determine if changes in food preference will affect the weight 
and total food intake of these rats. 
 
Initial speculations of the NI being involved in the regulation of anxiety responses 
emerge as a result of mapping studies that revealed NI projections into the presumed 
regions of anxiety regulation, particularly the various nuclei of the amygdala, median 
raphe, hippocampus and thalamus (Goto et al., 2001; Olucha-Bordonau et al., 2003). 
Besides, there has been convincing evidence linking the NI to stress responses, whose 
circuitry overlaps and interacts with the anxiety pathway. Stressors such as restraint 
stress (Senba et al., 1993; Cullinan et al., 1995), forced swim stress (Cullinan et al., 
1995; Banerjee et al., 2010), a combination of restraint and water immersion stress 
(Tanaka et al., 2005) and even elevation stress (unpublished results from our lab) have 
been shown to activate the NI. The NI also has a high expression of CRF1, a receptor 
upon binding to CRF has been known to initiate hypothalamic and extra-hypothalamic 
responses to stress (Herman and Cullinan, 1997; Bale and Vale, 2004). 
Epidemiologically, depression (which may be equated to prolonged stress) is highly 
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comorbid with anxiety disorders like post-traumatic stress disorder (PTSD) and panic 
disorders (Reiger et al., 1990). These prompt us to look at the behaviour of these NI-
lesioned rats in tests for anxiety. 
 
The NI-lesioned rats were subjected to 3 separate paradigms designed to measure 
anxiety-like behaviour, namely the elevated plus maze, novelty suppression of feeding 
and the light/dark box. Each of these paradigms involved putting the rats in an 
environment designed that presented them with two conflicting desires.  Rats are 
naturally inquisitive animals and like to explore novel areas, however, they are also 
fearful and try to avoid places that may expose them to attacks from predators. 
 
The elevated plus maze is one of the most commonly used test for anxiety-like 
behaviour (Hoggs, 1996) and regularly used in the screening for anxiolytic agents 
(Dawson and Tricklebank, 1995). It is based on the rats’ innate aversion of open 
spaces and reflects the conflict between exploration and the distress of elevated open 
arms (Pellow et al., 1985). Rats prefer to remain in the walled arms of the maze, 
although their curiosity lures them out to the open arms for short periods of times. 
Hence the amount of time spent in the open arms can be negatively correlated to 
levels of anxiety.  
  
The novelty suppressed feeding test, based on the rodents’ fear of exposing itself to 
predators against its need to feed (Badnoff et al., 1989; Olivier et al., 2008) is   
occasionally used in the assessment of anxiolytics (Francis-Oliveira et al., 2013). In 
response to fear-inducing stimuli, rats displayed increased vigilance and a suppression 
of appetitive behaviour. When food deprived rats are presented with food in a novel 
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test environment, an increase in time (latency) to start feeding and a decrease in the 
amount of time spent feeding is an indication for anxiety-like behaviour. 
 
The light-dark box test is based on the rodents’ conflict between exploring a novel 
environment and its dislike for brightly illuminated spaces (Bourin and Hascoet, 
2003). Previously designed for mice, the light dark box setup had also been used in rat 
studies to much success (Chaouloff et al., 1997). Rats are introduced to the arena 
where they can either choose to spent time in the “dark side” or the “light side” where 
it is bright lit and therefore aversive. Hence, a reduction in the amount exploratory 
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3.2 Materials and Methods 
 
3.2.1 Animals and surgery 
 
The surgeries were completed as discussed in the previous chapter (Page 27) and a 
total of 72 male SD rats were used in this study. Blank or CRF-saporin was injected in 
a single blind manner and the identification of the treatment was only revealed at the 
end of the behavioural tests. Similarly, the rats were allowed to rehabilitate for 14 
days before any experiments were carried out. During the recovery period, the sham- 
and NI lesioned rats were handled for ten minutes daily to ease any anxiety due to the 
researcher and handling process during the behavioral experiments. With exception of 
the food intake and food preference test, all other behavioural experiments were 
carried out between 10 a.m. and 3 p.m. Rats were acclimatized to the darkened 
experimental room for at least two hours prior to behavioural testing.  
 
3.2.2 Food intake and weight measurement 
 
All food intake and weight measurement experiments were carried out in the 
individual home-cage of each rat. Prior to the start of the experiment, 400 g of 
standard lab chow was weighed and placed on a metal feed rack inside the cage. Rats 
were weighed and then returned to their home-cages. Water continued to be supplied 
ad libitum. Food consumed and weight of the rats were measured every morning and 
recorded. The bedding will be examined to collect any small feed pellets that may 
have dropped while the rats were feeding and included in the weighing. The total food 
intake and weight changes over 14 days were tabulated and analyzed. 
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3.2.3 Food preference test 
 
The food preference test was carried out in the individual home-cages of the rats. Two 
plastic containers were filled to the brim with 100 g of standard lab chow and 30 g of 
fruit loops (high sugar diet) (Jarosz et al 2006; Jarosz et al; 2007) and placed at 
opposite corners of the home-cage. The positions of these containers were changed 
daily to prevent any place preference bias. The amount of each type of feed consumed 
by the rats was measured every morning and then replenished daily. Any feed pellet 
or fruit loops that may have fallen into the bedding are picked out and included in the 
weighing. The experiment lasted for 14 days after which the rats were sacrificed to 
verify the lesion. 
 
3.2.4 Fear conditioning 
 
Sham- and NI-lesioned rats were subjected to a fear conditioning paradigm (King and 
Williams, 2009) 14 days after surgery. The rats were first habituated to a 46 cm by 46 
cm by 40 cm clear walled conditioning chambers with metal grid flooring (TSE 
Systems Inc., USA) for 15 min a day for four days before the fear training. The 
training phase consisted of a two minute pause, and six repeats of 30s tone with a 0.8 
mA shock presented in the last two seconds of the 30 s tone. During the test phase 24 
hours later, the tone was sounded for 30 s without the shock. The time spent freezing 
was recorded with the automated TSE system for five minutes following the tone. 
Freezing was filtered by a threshold of five seconds such that it was only considered if 
the rat froze for more than five seconds. The fear conditioning chambers were wiped 
down with 70% ethanol and allowed to dry before and between each animal.  
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3.2.5 Open field test 
 
The large open field was a 114 cm diameter circular arena, bordered by a 40 cm high 
opaque white wall, set on the floor of an enclosed experimental room. The experiment 
was done under low light illumination (about 5 lux). Using the EthoVision XT 
(Noldus, The Netherlands) software, the “centre” was defined as the central, circular 
40 cm diameter region while the “peripheral” annulus formed a 37 cm wide ring 
encircling the “centre”. To begin the five minute trial, sham- and NI lesioned rats 
were introduced to the edge of “periphery” from the same side of the open field and 
allowed to freely explore the arena. The cameras were mounted directly above the 
open field to allow ease of recording. The automated EthoVision software tracked the 
movement of the rats and recorded the total distance travelled, time spent in, number 
of entries and latency to enter the centre. The apparatus was cleaned thoroughly with 
70% ethanol and allowed to dry before and between each animal. 
 
3.2.6 Elevated plus maze 
 
The elevated plus maze setup consisted of four arms (each arm 46.5 cm long and 20 
cm wide) elevated 58 cm off the ground.  The two opposite “closed arms” comprised 
of 23 cm high opaque walls while the two remaining exposed arms were designated as 
the “open arms” (Pellow et al., 1985). The setup was placed in a circular water maze 
in the middle of the dimly lit arena (about 5 lux) and the surrounding was cleared of 
any visual cues. Rats were introduced to the central square region, facing the same 
open arm for all rats tested, and allowed to explore the plus maze for five minutes. 
The number of entries and time spent in the open arms as well as the amount of time 
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spent in the closed arms was recorded by the EthoVision software. The plus maze was 
wiped down with 70% ethanol before and between each animal to prevent any 
confounding factors due to olfactory cues. 
 
3.2.7 Novel environment suppression of feeding test 
 
Eighteen hours before the test, all feed was removed from the cages and rats were set 
to fast. Water continued to be provided. The behavioural test was carried out in a 
modified open field setup. The same 114 cm diameter circular arena, bordered by a 40 
cm high opaque white wall was used. Set in the middle of the dimly lit room, a dish 
filled with standard lab chow was placed in the centre of the open field. As designated 
by EthoVision, the “feed area” was defined as the central, circular 40 cm diameter 
region encompassing the feed dish while the “peripheral” formed a 37 cm wide ring 
around the “feed area”. The rats were introduced to the “periphery” and allowed to 
explore the arena freely. The number of entries and time spent in feed area were 
recorded by the EthoVision XT software. The arena was wiped down 70% ethanol 
and feed replaced between each rat.  
 
3.2.8 Light-dark box 
 
The light-dark setup was constructed as a 60 cm by 30 cm box with the top exposed to 
allow for easy recording (Bronjo Medi, Singapore). The half of the box that was 
defined as “dark box” was painted with a layer of opaque black paint while the 
transparent “light box” was covered with a layer of white paper to block out the 
surrounding. The light side was lit by a bright studio lamp (750 lux) to create an 
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aversive area. A small hole (10 cm by 8 cm) present at the bottom of the middle panel 
allowed the rats to move freely between the light and dark side. The rats were always 
introduced to the light side and the number of entries and time spent exploring the 
light side was recorded for five minutes. Due to some technical issues that arise when 
tracking the rats at the interface of the light and dark side, the total time recorded for 
the light and dark box may not always be equal to the entire test time. Between each 
rat, the box was wiped down with 70% ethanol.  
 
3.2.9 Data collection and statistical analysis  
 
Date recorded by the automated TSE fear conditioning system or EthoVision software 
was exported and tabulated in Excel. Thereafter, statistical analysis of these data was 
carried out using the GraphPad Prism software. Weight, food intake and food 
preference measurements of sham (n=6) and NI-leisoned (n=6) were analysed with a 
two-way ANOVA to determine if the interaction between time and the lesion had an 
effect on the results. As for fear conditioning (n=10 for sham and n=8 for NI-
lesioned), large open field, elevated plus maze, novel environment suppression of 
feeding (n=9 for sham and n=9 for NI-lesioned) and the light dark box (n=6 for sham 
and n=6 for NI-lesioned), an unpaired t test was used to analyze the tabulated data. 
Generation of graphs used in figures was conducted with the GraphPad Prism 
software. P<0.05 was considered statistically significant and all data were reported as 









3.3.1 No apparent difference in weight and food intake of sham- and NI-lesioned 
rats 
 
To determine if there were any alterations in weight and food intake of NI-lesioned 
rats, animal weights and amount of standard lab chow (Figure 3.1) eaten were 
measured every morning for 14 days. There were no significant weight differences 
between the two groups of rats (Figure 3.1A). However, as observed in figure 3.1A, 
NI-lesioned rats seemed to be marginally smaller than the sham lesioned group. The 
daily food intake for both sham- and NI-lesioned rats were not significantly different 
although the total amount of standard lab chow consumed by the NI-lesioned rats 
appear to be slightly lesser than the sham group (Figure 3.1B). 
 
3.3.2 NI-lesioned rats displayed a preference for sugary food 
 
In a separate experiment, sham- and NI-lesioned rats were presented with a choice of 
standard lab chow and fruit loops (high sugar diet) and the amount of each diet 
measured daily for 14 days. As observed previously, there was no apparent difference 
in the weights of the sham- and NI-lesioned rats as measured in the 14 days (Figure 
3.2A). Total food intake (standard lab chow and fruit loops) was also not altered in 
both groups of rats, though there was a modest but insignificant elevation in the total 
amount of food consumed in the first couple of days (Figure 3.2B).  Despite that, 
there was a distinct shift from the fruit loops diet to the standard lab chow for the NI-
lesioned rats (Figures 3.2C and D). The percentage of fruit loops consumed by the NI-
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lesioned rats started to decrease from the fifth day compared to the consistent intake 
by the sham lesioned rats. This variation in the amount of fruit loops consumed by the 
NI-lesioned rats was most obvious from the 9th day, where the decrease in fruit loops 
intake was significantly lesser as compared to the sham lesioned group (Figure 3.2C). 
The NI-lesioned rats’ preference for standard lab chow was indicated by the 
substantial increase in its intake, especially between the 9th and 14th day (Figure 
3.2D).  
 
3.3.3 NI-lesioned rats displayed increased freezing in a cued fear conditioning 
test compared to sham lesioned rats. 
 
Extreme fear appears to be a characteristic of many anxiety disorders, hence to 
determine if the CRF-saporin targeted lesioning of the NI had any impact on fear 
responses, sham- and NI-lesioned rats were tested in a cued fear conditioning 
paradigm. 24 hours after the rats were trained, the time spent freezing in response to 
the tone was recorded. The threshold was set such that the rats are required to freeze 
continuously for at least five seconds before freezing activity was recorded. The NI-
lesioned rats exhibited increased fear as indicated by the larger percentage of time 
spent freezing (51.90 + 6.00%) in comparison with 7.40 + 1.92% in the sham lesioned 



























Figure 3.1. Effect of NI lesioning on food intake and weight. Two weeks after the 
surgery, the weight, F(1,130)=1.28, p=0.2845 (A) and food intake, F(1,130)=2.61 
P=0.1369 (B) of sham lesioned (n=6) and NI-lesioned (n=6) rats were recorded daily 
for 14 days. Data is represented as mean ± SEM. No difference was observed in the 













Figure 3.2. Effect of NI lesioning on food preference. After two weeks of recovery 
from the surgery, the sham lesioned (n=6) and NI lesioned rats (n=6) were tested in a 
food preference test where rats were given a choice of standard lab chow (high 
protein) or fruit loops (high sugar) diet. Weight, F(1,130)=1.90 p=0.1977 (A), total 
daily food intake (standard lab chow and fruit loops), F(1,130)=5.47, p<0.05 (B), 
percentage of high sugar feed ate, F(1,130)=20.37 p<0.01 (C) and percentage of 
standard lab chow intake (D) were recorded once daily for 14 days. Data is 





















Figure 3.3. Effect of NI lesioning on behaviour of rats in a cued fear conditioning 
paradigm. Sham lesioned (n=10) and NI-lesioned (n=8) rats were subjected to a cued 
fear conditioning test. 24 hours after the training phase, the percentage freezing time 
of sham- and NI-lesioned rats were analysed and represented graphically wherein the 
data is represented as mean ± SEM  **p<0.01. Increased freezing time was observed 
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3.3.4 No significant difference in distance travelled for both groups of rats but 
NI-lesioned showed decreased entries and time spent in the centre of the open 
field.  
 
In order to check if the lesioning of the NI affects the motor coordination of the rats, 
the sham and NI-lesioned rats were allowed to explore the open field arena in a dimly 
lit room. The results revealed that there was no significant variation in the total 
distance covered by sham- and NI-lesioned rats in the open field (Figure 3.4A). In an 
attempt to uncover clues about the NI’s role in anxiety, the latency to enter the centre 
of the open field, number of entries to and percentage time spent in the centre (Figure 
3.4) were also analysed. The NI-lesioned rats took more than twice the amount of 
time to enter the centre of the arena when compared to the sham-lesioned group 
(p=0.0045; Figure 3.4B). It was also observed that the NI-lesioned rats had an average 
of one entry into the centre compared to four entries of the sham lesioned group 
(p=0.0078; Figure 3.4C). The NI-lesioned rats also spent noticeably less time 
exploring the centre of the open field (0.57 + 0.20%), a quarter of the time spent by 
sham lesioned rats (1.96 + 0.47%) (p=0.0158; Figure 3.4D). 
 
3.3.5 NI-lesioned rats showed a reduction in open arm exploration time on an 
elevated plus maze. 
 
Since the NI-lesioned rats displayed slight changes in anxiety responses in the open 
field, the rats were subsequently subjected to an elevated plus maze test. NI-lesioned 
rats displayed heightened levels of anxiety behaviour as observed by the decreased 
percentage of entries into both open arms (28.24 + 8.76%) compared to sham lesioned 
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rats (50.6 + 4.10%) (p=0.0053; Figure 3.5A). The amount of time spent exploring the 
open arms are an indication of anxiety behaviour of rats. Anxious animals will show 
reduced exploration time in the open arms and a preference to remain in the safer 
closed arms. The results acknowledged that and demonstrated that NI-lesioned rats 
spent substantially less time (13.96 + 4.41% vs. 41.74 + 2.74%) in the open arms 
(Figure 3.5B) in comparison with the sham lesioned group (p<0.0001). In addition, 
the NI-lesioned rats also spent significantly more of their time in the more secure 
closed arms (Figure 3.5C) in contrast to the sham lesioned group.  
 
3.3.6 NI-lesioned rats had a longer latency in entering the feed area of a novel 
environment. 
 
In a novel environment suppression of feeding test, rats were allowed to explore the 
arena with feed placed in the centre of the modified open field. Increased latency to 
start feeding due to exposure to a novel environment is a hint of anxious behaviour. 
Here I showed that the NI-lesioned rats took a significantly longer time to enter the 
feed area compared to sham lesioned rats (p=0.0434; Figure 3.6A). These rats also 
had a lesser number of entries into the feed area (1.67 + 0.60 vs. 8.4 + 1.06) in 
contrast to the sham lesioned rats (p<0.0001; Figure 3.6B). Besides, the percentage of 















Figure 3.4. Effect of CRF-saporin targeted lesioning of the NI on the behaviour of 
rats in a large open field. Sham lesioned (n=9) and NI-lesioned (n=9) rats were 
introduced to a large, dimly illuminated open field and allowed to explore the arena 
freely for five minutes. The total distance covered (A), latency to centre of the open 
field (B), number of entries (C) and percentage time spent by the rats in the centre (D) 
was recorded by EthoVision tracking system and analysed. The data is represented 
graphically as mean ± SEM where *p<0.05 **p<0.01. NI-lesioned rats demonstrated 














Figure 3.5. Effect of NI lesion on the behaviour of rats in an elevated plus maze. 
Sham lesioned (n=9) and NI-lesioned (n=9) rats were placed in the centre of an 
elevated plus maze and allowed to explore the area freely for five minutes. The 
number of entries and time spent in the open and closed arms were recorded and 
analysed. (A) Represents the percentage of entries into the open arms, calculated out 
of the total entries to the arms. The percentage of time spent exploring the open arms 
(B) and closed arms (C) and the data represented graphically as mean ± SEM  where 
*p<0.05 ***p<0.001. The NI-lesioned rats spent significantly less time exploring the 















Figure 3.6. Behaviour of NI lesion rats in a novel environment suppression of 
feeding test. After an 18 hours overnight fast, sham lesioned (n=9) and NI-lesioned 
(n=9) rats were introduced into a modified open field with feed placed in the centre of 
the arena and allowed to explore for six minutes.  Time taken for the rats to start 
feeding (A), number of entries into the feed area (B) and time spent in the feed area 
was recorded and analysed with an unpaired t test. (C) Displays the percentage of time 
the rats spent in the feed area. All data were represented graphically as mean ± SEM, 
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3.3.7 NI-lesioned rats spent less time in the aversive light box 
 
In the final test for anxiety behaviour, sham- and NI-lesioned rats were exposed to a 
light-dark box test. The results corroborated with the initial findings that NI-lesioned 
rats displayed anxious behaviour. These rats showed a trend of entering the light area 
less (Figure 3.7A) and spent substantially less time exploring the light box (p=0.0049; 
Figure 3.7B) when compared to sham lesioned rats. Furthermore, in comparison to the 
sham lesioned rats, the NI-lesioned rats seemed to prefer the less harsh dark box and 















Figure 3.7. Effect of NI lesion on behaviour of rats in a light dark box. Sham 
lesioned (n=6) and NI-lesioned (n=6) rats were introduced into the light side of a light 
dark box and allowed to explore the arena for five minutes. The number of entries into 
the light box (A) time spent exploring the light and dark sides were recorded by the 
EthoVision software. (B) and (C) represents the percentage of time the rats spent in 
the light (aversive) and dark box respectively. The data is represented graphically as 
mean ± SEM where **p<0.01 NI-lesioned rats displayed a markedly reduced time 













The above results showed that the weights of NI-lesioned rats do not vary from that of 
the sham lesioned rats, a result that is largely in agreement with the studies involving 
relaxin-3 knockout mice (Smith et al., 2009; Watanabe et al., 2011). Unaltered daily 
food intake measurements between the sham- and NI-lesioned groups seemed to 
suggest that the NI may not be primarily involved in feeding responses. Although 
many studies single out relaxin-3 as the neuropeptide involved in orchestrating the 
functions of the NI in feeding responses, there are only moderate relaxin-3 positive 
projections from the NI to the PVN and ARC of the hypothalamus (Tanaka et al., 
2005; Ma et al., 2007; Smith et al., 2011), hinting that relaxin-3 positive neurons from 
the NI may not as be crucial in appetite regulation. Thus the loss of relaxin-3 
expression brought about by the lesioning procedure may not have impacted the 
weights and food intake of the NI-lesioned rats. Moreover, studies which saw an 
increase in acute and chronic food intake in rats that were given ICV injections of H3 
(Hida et al., 2006; McGowan et al., 2006; McGowan et al., 2007) may not present an 
accurate picture of the endogenous function of relaxin-3, as the amounts of relaxin-3 
given was far more than the endogenous expression of the peptide 
 
As there was several compelling evidence of NI/relaxin-3 being involved in energy 
regulation and body weight gain (Hida et al., 2006; McGowan et al., 2006;; McGowan 
et al., 2007), I also looked at whether food preferences are different in NI-lesioned 
rats and if these changes can alter the weights of the rats. Interestingly, NI-lesioned 
rats showed less selection for a high sugar diet. However the weights and total food 
intake (standard lab chow + fruit loops) did not vary when compared to the sham 
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lesioned group. Although there was an alteration in diet selection, this did not impact 
the food intake and growth of the lesioned rats when compared to the sham group. A 
longer study can be carried out to determine if this choice in diet remains. 
Consumption of palatable food can produce a rewarding effect, a reaction and 
circuitry often linked to overeating and obesity.  Our results seem to suggest that the 
NI may regulate feeding indirectly by controlling the preference for palatable food. 
Though inadequate, these results may provide a limited baseline to look into the role 
of the NI in the reward seeking pathway, a circuitry that has been linked to “food 
addiction” and the development of obesity. 
 
The large open field test conducted under low levels of lighting was primarily set up 
to check if there were any locomotor differences between the sham- and NI-lesioned 
rats as this may hinder the rats’ behaviour in the later tests. The results showed that 
there were no differences in the total distance travelled for both the sham- and NI-
lesioned group, pointing out that the lesioning procedure does not affect locomotor 
activity. This also indicated that the differences observed in the subsequent battery of 
anxiety tests were due to altered levels or anxiety and not changes in locomotor 
activity. A brightly lit open field, where light presents an aversive stimulus, is 
typically used as a test for anxiety (Walsh and Cummins, 1979; Britton and Britton, 
1981), where rats would be apprehensive about exploring the centre of the arena. 
While analysing the distance data of the rats, I saw an interesting phenomenon. Even 
in a low light open field, the NI-lesioned rats entered and explored the centre less 
when compared to the sham lesioned rats. Instead they preferred the safer periphery, 
mostly moving near the walls of the arena. Though not the proper setup for test of 
anxiety behaviour, this presented a clue that the NI-lesioned rats may have some 
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underlying anxiety behavior that can be addressed in future experiments by increasing 
light intensity of the open field. 
 
A combat soldier suffering from PTSD may associate the sound of helicopters with a 
traumatic event and even years later, the helicopter’s sound continues to trigger a 
conditioned fear response. Thus, fear conditioning does resemble PTSD in certain 
aspects. In view of extreme fear being a distinctive feature of many anxiety disorders, 
the NI-lesioned rats were also tested in a fear conditioning paradigm. Increased 
freezing responses observed in NI-lesioned rats demonstrated that the tone itself could 
elicit the state of fear, suggesting that the NI-lesioned rats are more afraid or possibly 
more anxious than the sham lesioned group. Though there was not a complete loss of 
CRF1 expressing NI neurons (discussed in Chapter 2), it was sufficient to evoke an 
abnormal fear response (and anxiety-like behaviour), emphasizing the importance of 
the CRF1 positive neurons in the NI inregulating anxiety related behaviour. In an 
elevated plus maze test, the NI-lesioned rats demonstrated markedly reduced entries 
and time spent in the raised open arms, most likely due to their unease of being 
vulnerable on the elevated platform. Their preference to remain in the safer close arms 
implied that the NI-lesioned rats were particularly anxious. The anxious behaviour of 
these NI-lesioned rats was similar to several studies investigating anxiety-like 
behaviour in rats (Pellow et al., 1985; Pellow et al., 1986; Silva and Brandao, 2000; 
Korte and De Boer, 2003; Cai et al., 2012). These results suggested that even the 
partial loss of CRF1 expressing NI neurons can affected the anxiety state of rats, 
concurring with the notion that the NI is likely to be involved in regulation of anxiety-
like behaviour in rats.  
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Additionally, the NI-lesioned rats also display behavioural deficits in the novel 
environment suppression of feeding test where the rats had to decide between staying 
at the safer periphery or the uncertainty of venturing to the centre to feed (Olivier et 
al., 2008; Olivier et al., 2011).  A significantly longer time taken by the NI-lesioned 
rats to enter the feed area suggested that perhaps the intimidating novel environment 
stalled them from venturing to the feed area. Such elevated caution and suppression of 
feeding behaviour is associated with an increase in anxiety-like behaviour. Again, 
these results reinforced the belief that the NI is possibly involved in responding or 
evoking an anxiety response. The light-dark box, a test based on the innate aversion of 
rodents to brightly lit and novel environments, has been widely accepted as a test for 
anxiety and also in the screening of anxiolytics (Andrade and Graeff, 2001; Forestiero 
et al., 2006; Grivas et al., 2013; Ryan et al., 2013). The time spent in the light box is a 
measure for anxiety-like behaviour. In this assay, NI-lesioned rats clearly spent less 
time in the light box and instead preferred the more secure dark side, an obvious 
increase in anxiety-like behaviour. This observation was in line with the previous 
assays in which NI-lesioned rats display heightened anxiety responses. 
 
After a mapping study revealed projections of the NI into regions of the brain 
involved in anxiety (Goto et al., 2001; Olucha-Bordonau et al., 2003), many were 
quick to associate the NI with the neurocircuitry of anxiety. However these were 
largely speculations and few studies have examined the functional role of the NI in 
anxiety. The anxiety-behaviour of the NI-lesioned rats in the open field, elevated plus 
maze, novelty suppressed feeding and light-dark box is evidence that the loss of CRF1 
expressing neurons in these NI-lesioned rats resulted in the anxious phenotype. These 
results complemented a study carried out by Pereira and colleagues where electrical 
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lesions of the NI (characterized by the loss of calretinin immunoreactivity) led to a 
delay in the extinction of conditioned fear responses in these rats (Pereira et al., 2013), 
where deficits in fear extinction have been broadly linked to the etiology of post-
traumatic stress disorder (PTSD) (Milad et al., 2006). That said, the evident loss of 
regions encompassing the NI in the electrical lesion model cannot be overlooked 
(Pereira et al., 2013). Thus, it will be interesting to find out if these NI-lesioned rats 
have similar extinction deficits as that will provide additional information about the 
specific role the NI has to play in anxiety-like behaviour. The results from the five 
behaviour tests for fear and anxiety are to be pondered on, however, the list of anxiety 
tests is not exhaustive and shares various similarities to the different anxiety disorders. 
Further studies such as the social interaction test and shock probe burying tests are 
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In the previous chapter, the results demonstrated the importance of the NI in anxiety-
like behaviour, where the loss of the CRF1 (relaxin-3 and GAD65) expressing cells in 
the NI-lesioned rats led to an increase in anxiogenic behaviour. Given that the NI is 
the key source of relaxin-3 expression, it is not surprising that many studies of the NI 
associate its function to relaxin-3. Furthermore, a limited amount of evidence ranging 
from relaxin-3 fibres and RXFP3 mapping studies, to the behavioural effect of icv 
injection of human relaxin-3 indicates that relaxin-3 plays an important role in anxiety 
responses, namely eliciting an anxiolytic effect in rats. A contradicting finding in 
relaxin-3 knockout mice however, revealed that the lack of relaxin-3 in these mice 
results in an anxiolytic effect in an elevated plus maze test (Watanabe et al., 2011), 
raising more questions about whether and how relaxin-3 is involved in the regulation 
of anxiety-like behaviour. Bearing that in mind, the relaxin-3 knockout model may 
not present an accurate perspective of the role of relaxin-3 as the total absence of it 
may prompt compensatory mechanisms.  
 
Early tracing studies revealed reciprocal projections between the NI and the amygdala 
(Olucha-Bordanau et al., 2003), a region critically involved in the acquisition, 
retention and expression of conditioned fear responses and also emotional behaviour 
related to an aversive stimulus (Davis, 1992).  Subsequently, these projections were 
found to be relaxin-3 positive, albeit to varying levels. The central amygdala received 
a higher density of relaxin-3 positive projections compared to the medial amygdala 
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(Tanaka et al., 2005; Ma et al., 2007), implicating it as an important target of relaxin-3 
function. The central amygdala is known as the primary output region of the 
amygdala, which when activated, mediates many autonomic and behavioural 
responses associated with fear and anxiety (Davis, 1992; Roozendaal et al., 2009). A 
bulk of data has since elucidated the roles of the subregions of the amygdala in fear 
and anxiety. An extremely summarized version of the function and connections of the 
subregions of the amygdala in the expression of fear and anxiety involves the lateral 
nucleus of the amygdala receiving auditory information via projections from the 
posterior thalamus. The medial amygdala also receives olfactory stimuli and 
information of the internal hormonal state via its connections to the olfactory bulb, 
hypothalamus and preoptic nuclei. The information is gathered within the lateral 
amygdala and medial amygdala is then conveyed to the nearby basal nuclei where it 
sends reciprocal excitatory and inhibitory projections back to the lateral and medial 
nucleus. Excitatory projections from the basolateral complex project directly to the 
central nucleus of the amygdala or targets this information to the central nucleus via a 
series of GABAergic interneurons located between the nuclei, providing an effective 
means of controlling the activity of the central nucleus. The central amygdala, through 
its GABAergic projections to the brainstem, hypothalamus and forebrain regions, 
controls the expression of autonomic, hormonal and behavioural responses to emotive 
conditions. In addition, connections of the medial amygdala not only enable it to 
influence these physiological responses via its projections to the hypothalamic and 
brainstem nuclei, but also by modulating the activity in the central nucleus itself 
(Davis, 1992; Davis, 1994; Davis et al., 2001). That said, studies on the activity of the 
medial amygdala had revealed its negative regulation over the central nucleus, hence 
relaxin-3 infusion into the medial or central amygdala is likely to bring about a 
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different response. The more robust expression of RXFP3 in the central amygdala as 
compared to the medial amygdala also cannot be neglected (Sutton et al., 2004). 
 
Hence the aim of this chapter is to determine if H3 infusion into central amygdala can 
“rescue” the anxiogenic behaviour of these NI-lesioned rats in the cued fear 
conditioning, large open field, elevated plus maze, novelty suppressed feeding and the 
light/dark box. The human relaxin-3 peptide (H3) in this study had been used 
successfully in the study of relaxin-3 functions in feeding (McGowan et al., 2005; 
Hida et al., 2006; McGowan et al., 2006) and anxiety (Nakazawa et al., 2013). At the 
same time, H3 administration in the sham lesioned rats will also give some insight 
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4.2 Materials and Methods 
 
4.2.1 Surgery and implantation of cannula 
 
The surgeries for CRF-saporin targeted lesioning were carried out as previously 
described. A total of 45 SD rats were used for this study. After the infusion of CRF-
saporin or unconjugated saporin (single blind manner), the skull was cleaned and 
dried with 6% hydrogen peroxide. A scalpel was used to scratch the surface of the 
skull to aid the anchoring of the dental cement used later. Two pits were drilled into 
the skull adjacent to the cannulation side and screws were inserted to hold the cannula 
in place. A small hole was then drilled through the skull, relative to the bregma, AP: -
1.8mm, ML: +3.2mm for the medial amygdala (MeA) and AP: -2.0mm, ML: +3.8mm 
for the central amygdala (CeA) and a stainless steel guide cannula (8mm and 6mm 
below the pedestal for MeA and CeA respectively) was inserted to end just above the 
medial and central amygdala.  Self-curing dental cement was applied to fasten the 
cannula and screws in place, and once this was hardened the skin surrounding the 
dental cement was sutured and cleaned. A dust cap was inserted into the guide 
cannula to prevent blockage when not in use. Carprofen (5mg/kg) and enrofloxacin 
(10mg/kg) were given subcutaneously for five consecutive days and the health of the 
rats monitored daily post-surgery. The rats were rehabilitated for 14 days before any 
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4.2.2 Preparation of human relaxin-3 peptide and intra-amygdala infusion 
 
Human relaxin-3 (H3) was purchased from Phoenix Pharmaceuticals (Belmont, CA, 
USA) and dissolved in saline to a concentration of 900pmol/µl. One µl aliquots, 
stored at -20oC, were taken out to thaw just prior to the experiments. Prior to each 
behavioural experiment (before test phase for fear conditioning), a 180pmol/0.2µl 
solution of human relaxin-3 (McGowan et al., 2006) or 0.2µl of saline (single blind) 
was administered via the guide cannula into the medial or central amygdala over a 
minute. The infusion cannula projecting 1mm below the end of the guide cannula (9 
mm for medial and 7 mm for central) was left in place for another minute to allow for 
diffusion and prevent any backflow before withdrawal. The rats were held for a 
further four minutes before introduction to the behavioural arenas. 24h after the 
completion of the final behaviour test, the rats were injected with 0.2µl of 1% 
pontamine sky blue to verify the placement of the cannulae (Sigma Alrich, USA), 
given an overdose of pentobarbitone and perfused (perfusion described in greater 
detail in Chapter 2). Only those animals with the correct cannula placement were 
included in the data analysis. 
 
4.2.3 Behavioural experiments 
 
The behaviour setups for fear conditioning, large open field test, elevated plus maze, 
novel environment suppression of feeding test and light dark box test were described 
in the previous chapter (Page 48-51). The rats were randomly assigned to peptide or 
vehicle groups and subsequently introduced to the test arenas five minutes after 
receiving H3 or saline injections. The tracking and recording of the rats’ movement in 
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the setups were also similar to that as discussed in the previous chapter. As the 
majority of the data was generated by automated software analysis, they were not 
affected by any possible observer bias. After each experiment, the dust cap was placed 
back into the guide cannula to prevent any blockage. The rats were returned to their 
home cages and at least 72 hours (Ryan et al., 2013) were given before the next test to 
allow the peptide to wash out.  
 
4.2.4 Data collection and statistical analysis 
 
Data recorded by the automated TSE fear conditioning system and EthoVision 
software was exported and tabulated in Excel. Thereafter, statistical analysis was 
carried out using the GraphPad Prism software. Statistical significance was routinely 
calculated for the behaviour of sham-lesioned rats + saline (n=4), sham-lesioned rats 
+ H3 (n=5), NI-lesioned rats + saline (n=6) and NI-lesioned rats + H3 (n=6) with a 
cannula implanted at the medial amygdala and sham-lesioned rats + saline (n=6), 
sham-lesioned rats + H3 (n=6), NI-lesioned rats + saline (n=6) and NI-lesioned rats + 
H3 (n=6) with a cannula implanted at the central amygdala using an unpair t test, 
unless otherwise stated. Generation of graphs used in figures was conducted with the 
GraphPad Prism software. P<0.05 was considered statistically significant and all data 
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4.3.1 Relaxin-3 reverses freezing behaviour of NI-lesioned rats 
 
The total distance travelled during the habituation phase was reviewed (data not 
shown) to ensure that there were no differences in locomotor activity among the 
groups of rats tested. Here, the effect of H3 infusion into the medial/central amygdala 
of sham and NI-lesioned rats in retrieval of fear memory was tested. Just as observed 
before, NI-lesioned rats which were given saline infusions into the medial or central 
amygdala displayed increased freezing times when compared to the saline sham 
lesioned rats (Figure 4.1). Administration of H3 into the medial amygdala of NI-
lesioned rats did not alter the freezing behaviour compared to the saline group (Figure 
4.1A). On the other hand, H3 infusion into the central amygdala of the NI-lesioned 
rats resulted in a significant reduction in freezing when compared to NI-lesioned rats 
which had saline administered (p=0.0364; Figure 4.1B). The percentage freezing 
times of these rats were almost similar to the sham lesioned rats which received saline 
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Figure 4.1. Effect of H3 infusion into the medial or central amygdala of sham and 
NI-lesioned rats on behaviour in a cued fear conditioning paradigm.  Sham 
lesioned+saline (n=4), sham lesioned+H3 (n=5), NI-lesioned +saline (n=6) and NI-
lesioned+H3 (n=6) rats were subjected to a cued fear conditioning test. 24 hours after 
the training phase, these rats received an injection of saline or H3 in the medial 
amygdala five minutes before the tone test phase. Likewise, Sham lesioned+saline 
(n=6), sham lesioned+H3 (n=6), NI-lesioned +saline (n=6) and NI-lesioned+H3 (n=6) 
rats underwent the same training but were given saline or H3 injections into the 
central amygdala instead. The percentage freezing time of rats receiving injections 
into the medial (A) and central (B) amygdala was analysed and represented 
graphically wherein the data is represented as mean ± SEM  *p<0.05. A marked 
reduction in freezing time was observed in NI-lesioned rats which were given a H3 
infusion into the central amygdala compared to the saline group. 
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4.3.2 Relaxin-3 does not affect exploratory activity but rescued anxiety-like 
behaviour in the open field when infused into the central amygdala 
 
To determine if relaxin-3 will affect the locomotor activity of the rats, 180 pmol of H3 
was infused into the central or medial amygdala of the sham- and NI-lesioned rats 
which were then tested in a large open field test. Infusion of H3 into the medial 
amygdala did not influence the distance travelled in both sham- and NI-lesioned rats 
(Figure 4.2A). Neither did H3 infusion into the central amygdala affect the total 
distance moved by both sham- and NI-lesioned rats (Figure 4.3A). As previously 
observed, NI-lesioned rats had significantly fewer entries and spent less time in the 
centre of the open field compared to the sham lesioned group (Figure 4.2 and 4.3). 
Therefore, I also examined the performance of these rats after H3 infusion. There 
were no discernible changes in the entries, time spent and latency to enter the centre 
between NI-lesion rats infused with the same amount of saline or H3 relaxin in the 
medial amygdala. A similar observation was also seen in sham lesioned rats infused 
with saline or H3 relaxin (Figure 4.2B-D). However, it was intriguing to note that H3 
infusion into the medial amydgala brought about a slight decrease in percentage time 
spent in the centre for sham lesioned rats but a trend of minor increase in the time 
spent in the centre for NI-lesioned rats when compared to the saline groups. 
 
On the contrary, H3 infusion into the central amygdala of NI-lesioned rats 
substantially increased the number of entries made into the centre of the open field 
(0.17 + 0.17 to 2.83 + 1.11) when compared with the saline group (p=0.0386). In 
sham lesioned rats as well, there was a similar trend of a modest increase in the 
number of centre entries in  
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Figure 4.2. Effect of H3 infusion into the medial amygdala of sham and NI-
lesioned rats on the behaviour in a large open field. Sham lesioned+saline (n=4), 
sham lesioned+H3 (n=5), NI-lesioned + saline (n=6) and NI-lesioned+H3 (n=6) rats 
were introduced to a large open field and allowed to explore the arena freely for five 
minutes. The total distance covered (A), latency to centre of the open field (B), 
number of entries (C) and percentage time spent by the rats in the centre (D) was 
recorded by EthoVision tracking system and analysed. The data is represented 
graphically as mean ± SEM where *p<0.05 **p<0.01. H3 infusion did not alter 
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Figure 4.3.  Effect of H3 infusion into the central amygdala of sham and NI-
lesioned rats on the behaviour in a large open field. Sham lesioned+saline (n=6), 
sham lesioned+H3 (n=6), NI-lesioned + saline (n=6) and NI-lesioned+H3 (n=6) rats 
were introduced to a large open field and allowed to explore the arena freely for five 
minutes. The total distance covered (A), latency to centre of the open field (B), 
number of entries (C) and percentage time spent by the rats in the centre (D) was 
recorded by EthoVision tracking system and analysed. The data is represented 
graphically as mean ± SEM where *p<0.05 **p<0.01. H3 infusion into the central 
amygdala did not alter locomotor activity of both the sham and NI-lesioned rats but 
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rats receiving H3 relaxin infusion (Figure 4.3C). Along with the increase in centre 
entries, the NI-lesioned rats which were subjected to H3 infusion into the central 
amygdala spent a significantly greater amount of time, about 1.42 + 0.39% of their 
time, in the centre of the open field compared to 0.05 + 0.05% in the saline group 
(p=0.0059), almost similar to the 1.51 + 0.51% spent by sham lesioned rats infused 
with saline. The same trend was observed in sham-lesioned rats which received 
relaxin-3 infusions in the central amygdala, albeit more negligible when compared to 
the saline group (Figure 4.3D). A moderate decreasing trend in the latency (256 + 
44.01s vs. 156 + 45.68s) to reach the centre of the open field was also detected in NI-
lesioned rats given H3 as compared to the saline group, but not seen in sham lesioned 
rats receiving H3 infusions (Figure 4.3B). 
 
4.3.3 Relaxin-3 increased open arm exploration in an elevated plus maze when 
infused into the medial or central amygdala of NI-lesioned rats 
 
These same rats were tested in an elevated plus maze to verify if H3 relaxin infusion 
into the medial or central amygdala had any effect on their behaviour in this maze. As 
previously observed, the NI-lesioned rats which had saline infusions into the medial 
or central amygdala displayed markedly reduced entries into and time spent the open 
arms as compared with the sham lesioned rats receiving saline infusions to the medial 
or central amygdala (Figure 4.4 and 4.5). H3 infusion into the medial amygdala of NI-
lesioned rats increased the percentage of open arm entries (71.76 + 13.28%) when 
measured against NI-lesioned rats which were infused with saline (31.94 + 8.32 %; 
p=0.0293). This outcome was not noticed in sham lesioned rats which were given 
either saline or H3 (Figure 4.4A). Likewise, there was a considerable increase in the 
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amount of time spent exploring the open arms for NI-lesioned rats (72.20 + 11.16 %) 
which were subjected to H3 relaxin infusion but not in NI-lesioned rats (24.21 + 9.48 
%) receiving saline injections (p=0.0083; Figure 4.4B). However, sham lesioned rats 
which received an infusion of H3 relaxin showed an unusual decline in the amount of 
time spent in the open arms (28.07 + 5.37 %; p=0.013) and an obvious increase in the 
percentage of time spent in the close arms (51.47 + 3.21 %; p=0.033) when compared 
with the saline sham group (58.32 + 7.69 %; 31.41 + 7.61 %; Figure 4.4B-C). 
 
There was only a slight trend of increase in the percentage of open arm entries for NI-
lesioned rats that received H3 relaxin in the central amygdala in comparison to the 
saline NI-lesioned group. The sham lesioned rats which had either saline or H3 
infusion, did not display any differences in the percentage of entries into the open 
arms of the elevated plus maze (Figure 4.5A). Nevertheless, there was a prominent 
difference in the percentage of time spent in the open arms between the H3 NI-
lesioned group and the saline group (41.88 + 8.69% compared to 14.04 + 5.33%; 
p=0.021). The amount of open arm exploration time did not differ in sham lesioned 
rats receiving either saline or H3 relaxin (Figure 4.5B). Percentage of time spent in 
the closed arms was unchanged in sham lesioned rats given saline/H3 but show a 
trend of a slight decrease in NI-lesioned rats receiving H3 relaxin in the central 
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4.3.4 H3 infusion into the central amygdala of NI-lesioned rats reduced their 
latency to start feeding in a novel environment 
 
The NI-lesioned rats which had a saline injection into the medial or central amygdala 
showed a clearly longer time taken to start feeding in a novel environment when 
compared to the control sham lesioned rats receiving saline infusions to the medial or 
central amygdala (327 + 32.99s vs. 131 + 64.39s and 314.3 + 45.72s vs. 90.80 + 
54.33s respectively). Besides, the percentage of time in the feed area was also lower 
in the saline injected NI-lesion rats (Figure 4.6 and 4.7) which was consistent with the 
results observed in the previous chapter. To further validate the earlier observations of 
the “anxiolytic” nature of relaxin-3 in NI-lesioned rats, sham- and NI-lesioned rats 
were tested in a novelty induced suppression of feeding test after receiving saline or 
H3 relaxin in the medial/central amygdala. Although there was a trend of slight 
increase in the number of entries into the feed area for NI-lesioned rats that received a 
H3 injection into the medial amygdala when compared against the saline NI-lesioned 
group, there was no apparent difference in the latency to enter the feed area between 
the two groups (4.6A-B). 
 
NI-lesioned rats which received a H3 infusion into the central amygdala on the other 
hand, had a markedly reduced latency (98.71 + 53.83s) to enter the centre feed area 
compared to the saline group (314.3 + 45.72s) (p=0.01; Figure 4.7A). This resulting 
time taken to first enter the feed area was not far from sham lesioned rats receiving a 
saline infusion (Figure 4.7A). The number of entries into the feed area did not differ 
much within the four groups, but a trend of slight increase in the number of entries 
and time spent in the feed area observed in NI-lesioned rats that received H3 when 
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Figure 4.4. Effect of H3 infusion into the medial amygdala of sham and NI-
lesioned rats its behaviour in an elevated plus maze. Sham lesioned+saline (n=4), 
sham lesioned+H3 (n=5), NI-lesioned+saline (n=6) and NI-lesioned+H3 (n=6) rats 
were placed in the central square of an elevated plus maze and allowed to explore the 
area freely for five minutes. The number of entries and time spent in the open and 
closed arms were recorded and analysed. (A) Represents the percentage of entries into 
the open arms, calculated out of the total approaches to the arms. The percentage of 
time spent exploring the open arms (B) and closed arms (C) and the data represented 
graphically as mean ± SEM  where *p<0.05 **p<0.01. H3 infusion into the medial 
amydala resulted in an increase in open arm entries and exploration in NI-lesioned 
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Figure 4.5. Effect of H3 infusion into the central amygdala of sham and NI-
lesioned rats its behaviour in an elevated plus maze. Sham lesioned+saline (n=6), 
sham lesioned+H3 (n=6), NI-lesioned+saline (n=6) and NI-lesioned+H3 (n=6) rats 
were placed in the central square of an elevated plus maze and allowed to explore the 
area freely for five minutes. The number of entries and time spent in the open and 
closed arms were recorded and analysed. (A) Represents the percentage of entries into 
the open arms, calculated out of the total approaches to the arms. The percentage of 
time spent exploring the open arms (B) and closed arms (C) and the data represented 
graphically as mean ± SEM  where *p<0.05. H3 infusion into the central amydala led 
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compared to the saline NI-lesioned group (4.7B-C).  A trend in the slight fall in the 
number entries made to the feed area by sham lesioned rats receiving a H3 infusion 
may be a consequence of the trend of marginal increase in the percentage of time 
spent in the feed area, though this difference was not significant (4.7B-C).  
 
4.3.5 Relaxin-3 alters the number of entries and time spent in the light box when 
infused into the medial amygdala of NI-lesioned rats 
 
Finally, these rats were tested in the light-dark box to inspect for behavioural 
alterations after relaxin-3 infusion. Like before, NI-lesioned rats which were given 
saline infusions to the medial or central amygdala enter the light side less and spent a 
significantly lesser amount of time in the light box in comparison to the saline sham 
lesioned group (Figure 4.8 and 4.9). For NI-lesioned rats receiving H3 infusions into 
the medial amygdala, there was a trend of increase in the number of entries made by 
these rats into the light side, 8.67 + 2.54 compared to about 3.67 + 0.76 in the saline 
group (Figure 4.8A). These rats also spent a significantly longer duration (49.93 + 
12.18 vs. 19.71 + 2.08 %; p=0.0345) exploring the light box and less time in the dark 
side (p=0.0330) as to that of the NI-lesioned rats receiving saline injections in the 
medial amygdala. This effect was not observed in the sham group receiving either 
saline of H3 infusions (Figure 4.8B-C). 
 
As for sham- and NI-lesioned rats implanted with a cannula directed at the central 
amygdala, H3 infusion did not significantly alter the entries and time spent in the light 
box for sham- and NI-lesioned rats (Figure 4.9). Nonetheless, it was useful to note the 
marginal increase in the number of entries into and time spent in the light box for NI- 
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Figure 4.6. Behaviour of sham and NI-lesioned rats given saline/H3 injections into 
the medial amygala in a novel environment suppression of feeding test. After an 18 
hours overnight fast, sham lesioned+saline (n=4), sham lesioned+H3 (n=5), NI-
lesioned+saline (n=6) and NI-lesioned+H3 (n=6) rats were introduced into a modified 
open field with feed placed in the centre of the arena and allowed to explore for six 
minutes.  Time taken for the rats to first enter the feed area (A), number of entries into 
the feed area (B) and time spent in the feed area was recorded and analysed with an 
unpaired t test. (C) Displays the percentage of time the rats spent in the feed area. All 
data were represented graphically as mean ± SEM where *p<0.05. H3 infusion did not 





                   CHAPTER FOUR: RELAXIN-3 REVERSES THE ANXIOUS 








Figure 4.7. Behaviour of sham and NI-lesioned rats given saline/H3 injections into 
the central amygala in a novel environment suppression of feeding test. After an 18 
hours overnight fast, sham lesioned+saline (n=6), sham lesioned+H3 (n=6), NI-
lesioned+saline (n=6) and NI-lesioned+H3 (n=6) rats were introduced into a modified 
open field with feed placed in the centre of the arena and allowed to explore for six 
minutes.  Time taken for the rats to first enter the feed area (A), number of entries into 
the feed area (B) and time spent in the feed area was recorded and analysed with an 
unpaired t test. (C) Displays the percentage of time the rats spent in the feed area. All 
data were represented graphically as mean ± SEM where *p<0.05. H3 infusion in NI-
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lesioned rats that received the H3 relaxin infusion when compared with the saline 
group (4.9A-B). Just as seen above, H3 infusion into the central amygdala of sham-
lesioned rats did not alter any behaviour of these rats as compared to those infused 
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Figure 4.8. Effect of H3 infusion into the medial amygdala on the behaviour of rats 
in a light dark box. Sham lesioned+saline (n=4), sham lesioned+H3 (n=5), NI-
lesioned+saline (n=6) and NI-lesioned+H3 (n=6) rats were introduced into the light 
side of a light dark box and allowed to explore the arena for five minutes. The number 
of entries into the light box (A) time spent exploring the light and dark sides were 
recorded by the EthoVision software. (B) and (C) represents the percentage of time 
the rats spent in the light (aversive) and dark box, respectively. The data is 
represented graphically as mean ± SEM where *p<0.05, **p<0.01 H3 infusion into 
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Figure 4.9. Effect of H3 infusion into the central amygdala on the behaviour of rats 
in a light dark box. Sham lesioned+saline (n=6), sham lesioned+H3 (n=6), NI-
lesioned+saline (n=6) and NI-lesioned+H3 (n=6) rats were introduced into the light 
side of a light dark box and allowed to explore the arena for five minutes. The number 
of entries into the light box (A) time spent exploring the light and dark sides were 
recorded by the EthoVision software. (B) and (C) represents the percentage of time 
the rats spent in the light (aversive) and dark box, respectively. The data is 
represented graphically as mean ± SEM where *p<0.05, **p<0.01 H3 infusion into 
the central amygdala did not significantly alter the behaviour of the NI-lesioned rats in 
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The previous chapter argues that the NI is involved in promoting fear responses as 
noted by the increased freezing behaviour exhibited by the NI-lesioned rats. In this 
chapter, we investigated whether relaxin-3 is indeed the neuropeptide orchestrating 
this response. Pre-test administration of H3 into the central amygdala of the NI-
lesioned rats and not the medial amygdala resulted in a reduction of freezing 
behaviour in these rats as compared to their respective saline groups, which was in 
agreement that the central nucleus is involved in the expression of conditioned fear 
response (Kapp et al., 1979; LeDoux et al., 1988). Interestingly, H3 infusion was able 
influence the action of the central amygdala, suggesting that relaxin-3 plays a role in 
fear expression and likely the decrease of it.  H3 infusion into the medial or central 
amygdala of sham lesioned rats did not alter freezing behaviour, seemingly suggesting 
that under normal conditions, excess relaxin-3 does not promote additional “remedy” 
for the fearful behaviour. It should be kept in mind, however, that these results were 
obtained upon the local injection of H3 into the central amygdala and the use of only 
the tone fear conditioning paradigms -especially so when the electrical lesions of the 
NI was implicated in delayed extinction of fear (Pereira et al., 2013). Additional 
studies involving other forms of fear memory and extinction such as contextual fear 
are needed to unravel the potential role and mechanisms of the NI and relaxin-3’s 
influence on conditioned fear behaviour. 
 
Locomotor activity was not altered by H3 infusion into the medial or central 
amygdala of sham and NI-lesioned rats. This outcome was similar to other studies that 
assessed the effect of relaxin-3 related peptides on locomotor activity in various 
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paradigms. For instance, chronic icv infusion of H3 into male Wistar rats produced no 
significant difference in locomotor activity in a Plexiglas box when tested at different 
time periods of the light and dark phases (Hida et al., 2006). In the previous chapter, it 
was noted that the NI-lesioned rats displayed an anxiety-like behavior in the open 
field and this behavior remained in NI-lesioned rats receiving either saline or H3 
infusion into the medial amygdala. However H3 infusion into the central amygdala of 
these lesioned rats clearly reverses this anxious behavior, implying that relaxin-3 is 
likely to be involved in the regulation of anxiety via the projections to the central 
amygdala. However, the use of large open field in a test for anxiety-like behavior had 
been criticized for its lack of predictive validity as it was not sensitive in the 
examination of certain anxiolytic agents (Prut et al., 2003). Also, the large open field 
test was set up in a dimly lit room as a test for locomotor activity, thus it would be a 
better test for the anxiolytic function of relaxin-3 in the more appropriate brightly 
illuminated open field meant for anxiety-like behavior.  
 
Intra-medial amygdala injection of H3 in NI-lesioned rats produced a clear anxiolytic 
effect in the elevated plus maze, reflected by increased percentage of entries and time 
spent in the open arms, indicators of anxiety-like behavior (Pellow et al., 1985). Since 
there were no clear alterations in locomotor activity of these rats, the differences 
observed is most like due to changes in the anxiety state rather than changes in 
activity. However, an unusual reduction in the percentage of time spent in the open 
arms, indicative of an anxious behavior, for sham lesioned rats that received a H3 
injection into the medial amygdala seems to suggest that an excess of relaxin-3 may 
bring about a feedback response. Otherwise, it may be possible that relaxin-3 can 
exert a bidirectional control of anxiety-like behaviour via the activation of different 
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groups of neurons in the medial amygdala or even another circuitry. Another possible 
explanation for the differences in response could be due to the activation of different 
receptors. Although relaxin-3 binds preferentially to RXFP3, the binding activity to 
RXFP1 cannot be ignored. Perhaps, subjecting the rats to the anxious environment 
stimulates the release of relaxin-3, saturating the RXFP3 receptors present. Excess H3 
may bind to another population of neurons expressing RXFP1, resulting in an 
opposite response. This could be further explored by pre-treating the rats with a 
selective RXFP1 and/or RXFP3 antagonist prior to the injection of H3 and testing on 
the plus maze. H3 administration into the central amygdala of NI-lesioned rats also 
showed an anxiolytic effect in the elevated plus maze as indicated by the increase in 
open arm exploration. Although the increase in open arms entries for these rats was 
not as prominent, this could be a consequence of the increased time spent in the open 
arms. Taken together, these results not only suggested that the NI is involved in the 
regulation but it possibly exerts its control via relaxin-3. 
 
There was a distinct attenuation of anxiogenic-like behaviour in NI-lesioned rats 
receiving an intra-central amydala infusion of H3, as demonstrated by the shorter time 
taken by these rats to enter the feed area in a novelty suppressed feeding test. These 
results allowed conclusions to be drawn on the involvement of relaxin-3 in the 
modulation of anxiety-like behaviour, but do not provide a complete profile. No 
alterations in the anxiety-like behaviour for sham lesioned rats, which received H3 
infusions also hints of the strict control of the relaxin-3 system in the brain. On a side 
note, the novelty suppressed feeding test is sensitive to the acute administration of 
anxiolytics (Francis-Oliveira et al., 2013) but also differently sensitive to chronic 
antidepressants over acute antidepressants. Hence it will be intriguing to find out in 
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chronic relaxin-3 infusion will produce an antidepressant like response, making 
relaxin-3 potentially an anxiolytic and antidepressant target for future studies. 
 
The previous chapter showed that NI-lesioned rats exhibited heightened anxiety-like 
behaviour in the light-dark box. In the current study, there was a clear decrease in 
anxiety-like behaviour in NI-lesioned rats receiving an intra-medial amygdala 
injection of H3 but not in the rats which received the injection in the central 
amygdala. An increase in light box entries and percentage time spent in the light box, 
markers of anxiety-like activity, suggested that relaxin-3 had an anxiolytic effect in 
the relaxin-3 deficient NI-lesioned rats. Where levels of endogenous relaxin-3 were 
not compromised, excess relaxin-3 did not appear to further correct anxiety-like 
behaviour. A bulk of research have revealed the central amygdala as the primary 
output region of the amygdala, which when activated, mediates behavioural responses 
associated with anxiety (Davis, 1992; Roozendaal et al., 2009), supporting the 
observations that H3 infusion into the central amygdala was able to rescue the 
anxiety-like behaviour of the lesioned rats in the large open field and novel 
environment suppression of feeding, tests that present themselves as inescapable 
novel environments. It appears that H3 infusion in the medial amygdala reversed the 
anxiety-like behaviour of these lesioned rats in the elevated plus maze and the light 
dark box, tests that present an escapable option, suggesting a possibility of relaxin-3 
being involved in preparing and adopting behavioural approaches to escape from their 
“stressful” situations, analogous to the proposed role of the NI (Ryan et al., 2011).   
 
 The difference in behaviour observed between the intra-medial amygdala infusion 
and intra-central amygdala infusion rats is probably due to relaxin-3 projections onto 
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different populations of neurons. Besides, relaxin-3 exerts its effects via binding to is 
cognate receptor, RXFP3 and the receptor expressing neurons in the medial and 
central amygdala may have different chemical properties. A previous study uncovered 
a high density of nitric oxide- (NO) producing neurons in the medial amygdala which 
are activated after threatening stimuli. Intra-medial amygdala microinjections of NO 
synthase inhibitors produced an anxiolytic-like effect in rats in an elevated plus maze 
and the light dark box, suggesting that these neurons in the medial amygdala may be 
involved in conditions of escapable stress (Forestiero et al., 2006). Although the 
RXFP3 expressing population of neurons in the medial amygdala are not well known, 
it may possible that relaxin-3 binding to RXFP3 in these neurons, inhibits the 
production of NO, and thus resulting in an anxiolytic-like effect.  
 
The findings generally demonstrated the ability of relaxin-3 to decrease the anxiety-
like behaviour in NI-lesioned rats which complemented the study already done 
(Nakazawa et al., 2013) and delivered more evidence that relaxin-3 possibly regulates 
anxiety-like behaviour, making it a potential target for anxiety disorders. Relaxin-3 
generally exerted anxiolytic-like effects in four different tests of anxiety, namely the 
large open field, elevated plus maze, novelty suppression feed and the light-dark box 
which were not associated with changes in locomotor activity. These results also 
support the notion that relaxin-3 affected the local neuronal network and limit the 
possibility of a general arousal-like effect. In the behaviour tests carried out in this 
chapter, only the acute effect of relaxin-3 on anxiety-like behaviour was investigated. 
Thus whether chronic relaxin-3 infusion in these NI-lesion rats will maintain or alter 
their behaviour remains debatable.  Importantly, these data also demonstrated the 
contrast in the behavioural effect of relaxin-3 when administered into the medial or 
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central amygdala. Other than the disparity in the expression of RXFP3 in the medial 
and the central amygdala, where a more robust RXFP3 expression was detected in the 
central compared to the medial amygdala, these results also raise the question of 
whether the RXFP3 expressing neuronal populations are different in the medial and 











5. Discussion, future directions and conclusion 
 
5.1 General discussion 
 
The present results are among the first to suggest that the NI along with local relaxin-
3/RXFP signalling in the medial and central amygdala may be involved in regulating 
anxiety-like behaviour. Existing results seemed inconsistent with this idea. However, 
the results presented in this thesis may answer some of the contradictions. On one 
hand, decrease in anxiety-like behaviour following icv relaxin-3 infusion suggests that 
relaxin-3 signalling may negatively regulate the hypothalamic-pituitary-adrenal 
(HPA), where the activation of HPA activity is related to stress and anxiety-like 
behaviour (Arborelius et al., 1999; Nakazawa et al., 2013). Yet icv administration of 
relaxin-3 increased CRF expression in the PVN, an outcome predicted to increase 
anxiety levels (McGowan et al., 2009; Watanabe et al., 2011). Though commonly 
used to investigate the functions of neuropeptides, icv administration of any one 
peptide can activate or deactivate a myriad of neural networks at the same time. The 
behavioural responses observed after the infusion, therefore, could be due excessive 
multiple activation/inhibition and complex interplay of various neurocircuits, and thus 
may not represent the true endogenous function of the peptide and the stringent 
regulation of the peptide. With that in mind, it is possible that the icv administration 
of relaxin-3 also activates the subnuclei of the amygdala, altering the GABA 
transmission to mediate behavioural responses to cope with or “overrule” the 
“stressful information” conveyed by the activation of the PVN. Indeed, the findings in 
the earlier chapters seemed to suggest that relaxin-3 regulation of the medial or central 
nuclei of the amygdala can alleviate anxiety-like behaviour, though only in the 




relaxin-3 (GAD65) deficient NI-lesioned rats. Interestingly, central administration of 
neuropeptide Y and neuropeptide S yields a similar pattern of amplified HPA axis 
activity combined with reduced anxiogenic-like behaviour, suggesting that the 
activation of the HPA axis via CRF does not necessarily equate to increase in anxiety-
like behaviour (Heilig et al., 1992; Suda et al., 1993; Smith et al., 2006; Okamura et 
al., 2007).   
 
GABA, an inhibitory neurotransmitter, had been long implicated in anxiety. 
Benzodiazepines (which act on GABA receptors) are first-line medications used in the 
treatment of several anxiety disorders (Shader et al., 1993). GABA is found in the 
relaxin-3 expressing neurons of the NI (Ma et al., 2007) and it is possible that relaxin-
3 can be co-released with GABA to exert its functions or modulate GABAergic 
functions pre- or post-synaptically. In the second chapter, the results showed that the 
CRF-saporin targeted lesioning of the CRF1 positive neurons in the NI resulted in the 
marked reduction in relaxin-3, along with decreased levels of GAD65. Subsequently, 
the NI-lesioned rats were shown to display anxiogenic-like behaviour in several 
behaviour tests, likely due to the reduction of both relaxin-3 and GABA. Besides, 
relaxin-3 infusion in the NI-lesioned rats never fully remedies the anxiety-like 
behaviour in these rats, suggesting that relaxin-3 was not the only modulator in the 
observed anxiogenic-like behaviour. Further investigations, however, are required to 
elucidate the modulatory effect of relaxin-3 on GABAergic function in anxiety-like 
behaviours. This could be done by using a combination of a GABA agonist and 
relaxin-3 infusions to access its effect in “rescuing” the anxiety-like behaviour in the 
NI-lesioned rats. 
 




The NI is located just caudal to the 5-HT abundant dorsal raphe nucleus, thus 
identifying it as a possible target for serotonergic intervention. An earlier finding 
reported that relaxin-3 gene expression in the NI was significantly elevated after 5-HT 
depletion by chlorophenylalanine (PCPA) administration. With evidence of the 
localisation of 5-HT1A receptors on the relaxin-3 positive neurons of the NI, 5-HT 
most probably negatively regulates relaxin-3 expression in the NI via these receptors 
(Miyamoto et al., 2008). The detection of relaxin-3 positive projections from the NI 
and RXFP3 expression in serotonin expressing regions such as the dorsal raphe 
nucleus (Ma et al., 2007) presents a possibility of these areas being modulated by the 
NI and relaxin-3. Dysregulation of the serotonergic system had been strongly 
associated with the underlying causes of several anxiety disorders (Barnes et al., 
1999; Ressler et al., 2000). Understanding the exact nature of relaxin-3 and serotonin 
interactions can provide further understanding of the pathophysiology of anxiety 
disorders.  
  
Intriguingly, the NI and relaxin-3/RXFP3 system are hypothesized to be involved in 
both arousal and anxiety based on their projections, brain localization and the 
somewhat limited behavioural findings. Preliminary experiments in rats demonstrated 
a correlation between the activation of the NI (indicated by Fos expression) and the 
levels of stressed-related locomotor activity. Increases in Fos expression were also 
detected in the NI just before food delivery, overlapping with a period of 
hyperactivity, arousal and aggressiveness (Goto et al., 2001). Besides, relaxin-3 
mRNA was thought to peak in the early dark phase, consistent with the notion of the 
NI and relaxin-3 being more active during the early dark or “arousal” phase. To some 
extent, this is a paradox as most drugs that are recognised to be arousing and 




activating tend to produce anxiety-like effects instead of anxiolytic effects, for 
example, amphetamines, cocaine, CRF and GABA antagonists (Sutton et al., 1982; 
Koob and Heinrichs, 1999; Koob et al., 2004). An exception to this relation is 
nicotine, which increases arousal and wakefulness but produces an anxiolytic effect 
(Nesbitt, 1973), a classic example of how arousal and anxiety do not always follow a 
monophasic pathway. Thus further characterisation of relaxin-3’s role in anxiety and 
arousal is needed to elucidate the separate systems that may underlie these two 
behaviours. In this study, relaxin-3 infusion into the medial or central amygdala of 
sham and NI-lesioned rats did not alter any locomotor behaviour nor promote 
hyperactivity, indicating that relaxin-3 mediates anxiogenic-like behaviour, not 



















5.2 Future directions 
 
The limited amount of data on the role of the NI in anxiety-like behaviour demands 
for further investigation. The tests for anxiety used in this thesis are based on anxiety 
manifesting as an inhibition of behaviour. However, the NI-lesioned rats should also 
be tested in paradigms where anxiety-like effects are reflected as an active response 
(e.g. marble/shock probe burying test). This will lend some additional assurance that 
nonspecific locomotor alterations are not influencing the measures of anxiety-like 
behaviour. Recording the neural activity of the NI neurons during the time when the 
rat is exposed to the behavioural arena will also provide “real time” measures of the 
function of the NI neurons in anxiety-like responses. This can be done by the 
implantation of a wireless multi-channel recording electrode (Mohseni et al., 2005; 
Fan et al., 2011) into the NI of the rats. Subsequently, freely behaving rats can be 
tested the different behaviour paradigms for anxiety-like behaviour. The recording 
system can be interfaced with data acquisition systems to provide a thorough mapping 
of the neural activity of the NI at the different points of the behaviour arena.  
 
An optogenetic approach (Deisseroth, 2010) can be adopted to study the function of 
the NI neurons, or more specifically, the relaxin-3 expressing neurons in the NI. In 
general, the opsins, namely Channelrhodopsin and Halorhodopsin, can be specifically 
targeted to the relaxin-3 positive neurons in the NI via a relaxin-3 specific promoter. 
Once expressed, these freely moving rats can be tested in a battery of tests for 
anxiety-like behaviour. During the test, delivery of blue/green light to the opsin-
expressing cells can precisely excite or inhibit the relaxin-3 positive neurons and the 
anxiety-like effects of this manipulation can therefore be measured.  




This thesis speculates that relaxin-3 intervention of the central and medial amygdala 
alleviates the anxiogenic-like behaviour in the NI-lesioned rats. Although it was 
previously reported that the relaxin-3 positive projections of the NI extends to these 
nuclei, there is limited evidence of a strong and direct projection from the NI to the 
medial and central nucleus of the amygdala. This can be studied by the injection of a 
retrograde tracer, for example, Fluoro-Gold (Naumann et al., 2000) into the medial or 
central amygdala. Retrogradely labelled cells can be examined to determine if the NI 
does indeed project to these regions or also immuno-labelled with relaxin-3, CRF1 or 
GAD65 antibodies to determine the chemical properties of these projections. 
Functionally, we can selectively damage the NI neurons projecting to the amygdala by 
the use of selectively photothermolysis (Madison et al., 1988; Madison and Macklis, 
1993; Macklis, 1993; Magavi et al., 2000). Briefly, projecting NI neurons can be 
targeted by the retrograde transport of a nontoxic chromophore from the 
medial/central nuclei which will produce cytotoxic singlet oxygen during 
photoactivation by a 670 nm light. Laser illumination of chromophore containing 
neurons will lead to the selectively degeneration and loss of the NI neurons projecting 
to the amygdala. The effect of the manipulation of the NI-amygdala projections can 
then be studied the behaviour tests for anxiety-like behaviour and the behavioural 
responses displayed by these “lesioned” rats may be correlated to the loss of NI-
amygdala projections.  
 
The sites of action of relaxin-3 in putative correlates of anxiety require further 
characterisation. This can be achieved by observing the behaviour responses of 
targeted injections of H3 into regions such as the basolateral amygdala, 
PVN/hypothalamic nuclei or hippocampus of NI-lesioned rats (a relaxin-3 deficient 




model). This discrepancy observed in some of the results could be due to relaxin-3 
binding to RXFP1. The effects brought about by this binding should not be neglected 
and can be investigated by using a combination of the relaxin-3, RXFP1 and RXFP3 
antagonist, R3(B∆23-27)R/15 (Liu et al., 2005; Kuei et al., 2007) on the behaviour 
response following its infusion.  
 
Some initial behaviour experiments have been performed with the use of relaxin-3 
knockout mice (Smith et al., 2009a; Watanabe et al., 2011; Smith et al., 2012), but the 
results may be confounded by the compensatory mechanisms that come into play. A 
similar experimental model in rats has been established, where relaxin-3 is “silence” 
by the AAV-driven miRNA (Callander et al., 2009; Callander et al., 2012). This 
relaxin-3 deficient model can therefore be used to investigate the role of relaxin-3 in 
anxiogenic-like responses by subjecting them to the tests paradigms for anxiety-like 
behaviour.  
 
There is significant scope for further investigation of the functions of the NI and the 
relaxin-3 system in anxiety behaviour. Importantly, this may shed light on the 
pathological pathways of anxiety disorders and interaction with the NI and/or the 
relaxin-3 system can potentially provide important therapeutic uses for anxiety 












In this study, I started out with the aim of establishing a method to selectively ablate 
the CRF1-expressing neurons in the NI of rats with the use of a specific CRF-
conjugated saporin. Unaltered expression of THP2 along with marked reduction of 
CRF1, relaxin-3 and GAD65 indicated that this toxin selectively targets and lesions 
the CRF1-expressing neurons in the NI. To study the effect of this lesion, the sham 
and NI-lesioned rats were subjected to several behaviour tests, namely fear 
conditioning, large open field, elevated plus maze, novelty suppressed feeding and the 
light-dark box, to investigate the role of the NI in anxiety-like behaviour. NI-lesioned 
rats displayed elevated levels of anxiogenic-like behaviour in these tests (compared to 
sham lesioned rats) which may be attributed to the loss of CRF1 positive NI neurons. 
Given that the NI is the chief source of relaxin-3 in the brain and recent reports 
suggesting of the anxiolytic nature of relaxin-3, I moved on to determine the effects of 
human relaxin-3 infusion into the medial and central amygdala, recognized projection 
targets of the NI, on the behaviour of NI-lesioned rats in the same paradigms. The 
findings in this thesis showed that H3 infusion in the medial/central amygdala 
produced an anxiolytic-like behaviour, effectively “rescuing” the anxious phenotype 
of the NI-lesioned rats. Collectively, these results proposed that the NI possibly exerts 
its modulatory role on anxiety-like behaviour via the relaxin-3 projections and 
interaction with the medial and central amygdala.  
 
 





Anand BK, Brobeck JR 1951 Localization of a "feeding center" in the hypothalamus 
of the rat. Proc Soc Exp Biol Med 77:323-324 
 
Andrade TG, Graeff FG 2011 Effect of electrolytic and neurotoxic lesions of the 
median raphe nucleus on anxiety and stress. Pharmacol Biochem Behav 70(1):1-14 
 
Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB 1999 The role of corticotropin-
releasing factor in depression and anxiety disorders. J Endocrinol 160(1):1-12 
 
Asin KE, Fibiger HC 1983 An analysis of neuronal elements within the median 
nucleus of the raphe that mediate lesion-induced increases in locomotor activity. 
Brain Res 268:211-223 
 
Bale TL, Vale WW 2004 CRF and CRF receptors: role in stress responsivity and 
other behaviors. Annu Rev Pharmacol Toxicol 44:525-557 
 
Banerjee A, Shen PJ, Gundlach AL 2006 Relaxin-3 neurons in nucleus incertus of the 
rat: effect on activity of psychological stress and the light-dark cycle. FENS Abstr 
3A117.2 
 
Banerjee A, Shen PJ, Ma S, Bathgate RAD, Gundlach AL 2010 Swim stress 
excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 
activation. Neuropharmacology 58:145-155 
 
Barnes NM, Sharp T 1999 A review of central 5-HT receptors and their function. 
Neuropharmacology 38(8):1083-1152 
 
Bathgate RAD, Ivell R, Sanborn BM, Sherwood OD, and Summers RJ 2006a 
International Union of Pharmacology LVII: recommendations for the nomenclature of 
receptors for relaxin family peptides. Pharmacol Rev 58: 7-31 
                                    
108 
 
Bathgate RAD, Lin F, Hanson N F 2006b Relaxin-3: improved synthesis strategy and 
demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in 
vitro and in vivo. Biochemistry 45:1043-1053. 
 
Bathgate RAD, Samuel CS, Burazin TCD, Layfield S, Claasz AA, Reytomas IG, 
Dawson NF, Zhao C, Bond C, Summers RJ, Parry LJ, Wade JD, Tregear GW 2002a 
Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene: novel 
members of the relaxin peptide family. J. Biol. Chem. 277:1148-1157 
 
Bennett RG, Dalton SR, Mahan KJ, Gentry-Nielsen MJ, Hamel FG,  Tuma DJ 2007 
Relaxin receptors in hepatic stellate cells and cirrhotic liver. Biochem Pharmacol 
73:1033-1040 
 
Billington CJ, Briggs JE, Grace M, Levine AS 1991 Effects of intracerebroventricular 
injection of neuropeptide Y on energy metabolism. Am J Physiol 260:321-327 
 
Bittencourt JC, Sawchenko PE 2000 Do centrally administered neuropeptides access 
cognate receptors? An analysis in the central corticotropin-releasing factor system. J. 
Neurosci. 20:1142-1156 
 
Bland BH 1986 The physiology and pharmacology of hippocampal formation theta 
rhythms. Prog Neurobiol 26(1):1-54 
 
Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ 1989 A comparison of the 
effects of diazepam versus several typical and atypical anti-depressant drugs in an 
animal model of anxiety. Psychopharmacology (Berl) 97(2):277-279 
 
Boston BA, Blaydon KM, Varnerin J, Cone RD 1997 Independent and additive 
effects of central POMC and leptin pathways on murine obesity. Science 278:1641-
1644 
 
Botly LC, De Rosa E 2009 Cholinergic deafferentation of the neocortex using 192 
IgG-saporin impairs feature binding in rats. J Neurosci. 29(13):4120-4130 
                                    
109 
 
Bourin M, Hascoët M 2003 The mouse light/dark box test. Eur J Pharmacol 463(1-
3):55-65 
 
Bremner JD, Narayan M, Staib LH, Southwick SM, McGlashan T, Charney DS 1999a 
Neural correlates of memories of childhood sexual abuse in women with and without 
posttraumatic stress disorder. Am J Psychiatry 156:1787-1795 
 
Britton DR, Britton KT 1981 A sensitive open field measure of anxiolytic drug 
activity. Pharmacol Biochem Behav 15(4):577-582 
 
Bryant RA, Kemp AH, Felmingham KL, Liddell B, Olivieri G, Peduto A et al 2008b 
Enhanced amygdala and medial prefrontal activation during nonconscious processing 
of fear in posttraumatic stress disorder: An fMRI study. Hum Brain Mapp 29:517-523 
 
Bullitt E 1990 Expression of c-fos-like protein as a marker for neuronal activity 
following noxious stimulation in the rat J Comp Neuro 296(4)517-530 
 
Burazin TC, Johnson KJ, Ma S, Bathgate RAD, Tregear GW, Gundlach AL 2005 
Localization of LGR7 (relaxin receptor) mRNA and protein in rat forebrain: 
correlation with relaxin binding site distribution. Ann N Y Acad Sci 1041:205-210 
 
Burazin TCD, Bathgate RAD, Macris M, Layfield S, Gundlach AL, Tregear GW 
2002 Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the 
dorsal tegmental region of brain. J. Neurochem. 82:1553-1557 
 
Cai L, Bakalli H, Rinaman L 2012 Yohimbine anxiogenesis in the elevated plus maze 
is disrupted by bilaterally disconnecting the bed nucleus of the stria terminalis from 
the central nucleus of the amygdala. Neuroscience 223:200-208 
 
Callander GE, Ma S, Ganella DE, Wimmer VC, Gundlach AL, Thomas WG, 
Bathgate RA 2012 Silencing relaxin-3 in nucleus incertus of adult rodents: a viral 
vector-based approach to investigate neuropeptide function. PLoS One 7(8):e42300 
 
                                    
110 
 
Callander GE, Thomas WG, Bathgate RA 2009 Development and optimization of 
microRNA against relaxin-3. Ann N Y Acad Sci 1160:261-264 
 
Campfield LA, Smith FJ, Guisez Y, Devos R,  Burn P 1995 Recombinant mouse OB 
protein: evidence for a peripheral signal linking adiposity and central neural networks. 
Science 269:546-549 
 
Cano G, Mochizuki T, Saper CB 2008 Neural circuitry of stress-induced insomnia in 
rats. J. Neurosci 28:10167-10184 
 
Cardin JA, Carlén M, Meletis K, Knoblich U, Zhang F, Deisseroth K, Tsai LH, 
Moore CI 2010 Targeted optogenetic stimulation and recording of neurons in vivo 
using cell-type-specific expression of Channelrhodopsin-2 Nat Protoc 5(2):247-254 
 
Chance WT, Dayal R, Friend LA, Sheriff S 2006 Possible role of CRF peptides in 
burn-induced hypermetabolism. Life Sci 78(7):694-703 
 
Chaouloff F, Durand M, Mormède P 1997 Anxiety- and activity-related effects of 
diazepam and chlordiazepoxide in the rat light/dark and dark/light tests.  Behav Brain 
Res 85(1):27-35 
 
Chen J, Kuei C, Sutton SW, Bonaventure P, Nepomuceno D, Eriste E, Sillard R, 
Lovenberg TW and Liu C 2005 Pharmacological characterization of relaxin-3/INSL7 
receptors GPCR135 and GPCR142 from different mammalian species. JPharmacol 
Exp Ther, 312:83-95 
 
Chong SA 2007 Mental health in Singapore: A quiet revolution? Annals, Academy of 
Medicine 36(10): 795-796 
 
Chong SA, Abdin E, Nan L, Vaingankar JA, Subramaniam M 2012 Prevalence and 
impact of mental and physical comorbidity in the adult Singapore population. Annals 
Academy of Medicine 41(3): 105-114 
 
                                    
111 
 
Chronwall BM, Skirboll LR, O’Donohue TL 1985 Demonstration of a 
pontinehippocampal projection containing a ranatensin-like peptide. Neurosci. Lett. 
53:109-114 
 
Clark JT, Kalra PS, Crowley WR, Kalra SP 1984 Neuropeptide Y and human 
pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427-429 
 
Contestabile A, Stirpe F 1993 Ribosome-inactivating proteins from plants as agents 
for suicide transport and immunolesioning in the nervous system Eur J Neurosci 
5(10):1292-1301 
 
Coons EE, Cruce JA 1968 Lateral hypothalamus: food current intensity in 
maintaining self-stimulation of hunger. Science 159:1117-1119 
 
Cooper SJ 1980 Effects of chlordiazepoxide and diazepam on feeding performance in 
a food-preference test. Psychopharmacology (Berl 69(1):73-78 
 
Cullinan WE, Herman JP, Battaglia DF, Akil H, Watson SJ 1995 Pattern and time 
course of immediate early gene expression in rat brain following stress. Neurosci 
64(2):477-505 
 
Davis M 1992 The role of the amygdala in fear and anxiety. Annu Rev Neurosci 
15:353-375 
 
Davis M, Shi C 1999 The extended amygdala: are the central nucleus of the amygdala 
and the bed nucleus of the stria terminalis differentially involved in fear versus 
anxiety? Ann N Y Acad Sci 877:281-291 
 
Davis M, Whalen PJ 2001 The amygdala: vigilance and emotion. Mol Psychiatry 
6(1):13-34 
 
Dawson GR, Tricklebank MD 1995 Use of the elevated plus maze in the search for 
novel anxiolytic agents. Trends Pharmacol Sci 16(2):33-36 
 
                                    
112 
 
Donizetti A, Fiengo M, Munucci S, Aniello F 2009 Duplicated zebrafish relaxin-3 
gene shows a different expression pattern from that of the co-orthologue gene. 
Develop. Growth Differ. 51:715–722 
 
Elias CF, Lee CE, Kelly JF, Ahima RS, Kuhar M, Saper CB,  Elmquist JK 2001 
Characterization of CART neurons in the rat and human hypothalamus. J Comp 
Neurol 432:1-19  
 
Elmquist JK 2001 Hypothalamic pathways underlying the endocrine, autonomic, and 
behavioural effects of leptin. Physiol Behav 74:703-708 
 
Fan D, Rich D, Holtzman T, Ruther P, Dalley JW, Lopez A, Rossi MA, Barter JW, 
Salas-Meza D, Herwik S, Holzhammer T, Morizio J, Yin HH 2011 A wireless multi-
channel recording system for freely behaving mice and rats. PLoS One 6(7):e22033 
 
Filonzi M, Cardoso L C, Pimenta MT, Queiroz DB, Avellar MC, Porto CS, Lazari 
MF 2007 Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA 
and protein distribution in the reproductive tract of the male rat. Reprod Biol 
Endocrinol 5:29 
 
Ford B, Holmes CJ, Mainville L, Jones BE, 1995 GABAergic neurons in the rat 
pontomesencephalic tegmentum: codistribution with cholinergic and other tegmental 
neurons projecting to the posterior lateral hypothalamus. J. Comp.Neurol. 363:177-
196 
 
Forestiero D, Manfrim CM, Guimarães FS, de Oliveira RM 2006 Anxiolytic-like 
effects induced by nitric oxide synthase inhibitors microinjected into the medial 
amygdala of rats. Psychopharmacology (Berl) 184(2):166-172 
 
Francis-Oliveira J, Ponte B, Barbosa AP, Veríssimo LF, Gomes MV, Pelosi GG, 
Britto LR, Moreira EG 2013 Fluoxetine exposure during pregnancy and lactation: 
Effects on acute stress response and behavior in the novelty-suppressed feeding are 
age and gender-dependent in rats. Behav Brain Res 252:195-203 
 
                                    
113 
 
Franklin KBJ, Paxinos G 2008 The mouse brain in stereotaxic coordinates, third ed. 
Academic Press, London 
 
Goto M, Swanson LW, Canteras NS 2001 Connections of the Nucleus Incertus. The 
Journal of Comparative Neurology 438:86-122 
 
Greenberg D, Weatherford SC 1990 Obese and lean Zucker rats differ in preferences 
for sham-fed corn oil or sucrose. Am J Physiol 259(6 Pt 2):R1093-5 
 
Grivas V, Markou A, Pitsikas N The metabotropic glutamate 2/3 receptor agonist 
LY379268 induces anxiety-like behavior at the highest dose tested in two rat models 
of anxiety. Eur J Pharmacol pii: S0014-2999(13)00467-6 
 
Gundlach AL, Ma S, Sang Q, Shen PJ, Piccenna L, Sedaghat K, Smith CM, Bathgate 
RAD, Lawrence AJ, Tregear GW, Wade JD, Finkelstein DI, Bonaventure P, Liu C, 
Lovenberg TW, Sutton SW 2009 Relaxin family peptides and receptors in the brain. 
Relaxin and Related Peptides: Fifth International Conference: Ann. N.Y Acad. Sci 
1160:226-235 
 
Hagan MM, Rushing PA, Pritchard LM, Schwartz MW, Strack AM, Van Der Ploeg 
LH, Woods SC,  Seeley RJ  2000 Long-term orexigenic effects of AgRP-(83---132) 
involve mechanisms other than melanocortin receptor blockade. Am J Physiol Regul 
Integr Comp Physiol 279:47-52 
 
Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, 
Burley SK,  Friedman JM 1995 Weight-reducing effects of the plasma protein 
encoded by the obese gene. Science 269:543-546 
 
Heckers S, Ohtake T, Wiley RG, Lappi DA, Geula C, Mesulam MM 1994 Complete 
and selective cholinergic denervation of rat neocortex and hippocampus but not 
amygdala by an immunotoxin against the p75 NGF receptor. J Neurosci 14(3 Pt 
1):1271-1289 
 
                                    
114 
 
Heilig M, McLeod S, Koob GK, Britton KT 1992 Anxiolytic-like effect of 
neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regul Pept 
41(1):61-9 
 
Herman JP, Cullinan WE 1997 Neurocircuitry of stress: central control of the 
hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20(2):78-84 
 
Hida T, Takahashi E, Shikata K 2006 Chronic intracerebroventricular administration 
of relaxin-3 increases body weight in rats. J Recept Signal Transduct Res 26:147-158 
 
Hogg S 1996 A review of the validity and variability of the elevated plus-maze as an 
animal model of anxiety. Pharmacol Biochem Behav 54(1):21-30 
 
Hong S, Flashner B, Chiu M, ver Hoeve E, Luz S, Bhatnagar S 2012 Social isolation 
in adolescence alters behaviors in the forced swim and sucrose preference tests in 
female but not in male rats. Physiol Behav 105(2):269-275 
 
Hsu LKG, Kaye W, Weltzin T 1993 Are eating disorders related to obsessive 
compulsive disorders? International Journal of Eating Disorders 14(3): 305-318 
 
Hummel M, Cummons T, Lu P, Mark L, Harrison JE, Kennedy JD, Whiteside GT 
2010 Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 
receptors. Neuropharmacology 59(3):160-166 
 
Jacobs BL, Wise WD, Taylor KM 1974 Differential behavioral and neurochemical 
effects following lesions of the dorsal or median raphe nuclei in rats. Brain Res 
79:353-361 
 
Jarosz PA, Kessler JT, Sekhon P, Coscina DV 2007 Conditioned place preferences 
(CPPs) to high-caloric "snack foods" in rat strains genetically prone vs. resistant to 
diet-induced obesity: resistance to naltrexone blockade. Pharmacol Biochem Behav 
86(4):699-704 
 
                                    
115 
 
Jarosz PA, Sekhon P, Coscina DV 2006 Effect of opioid antagonism on conditioned 
place preferences to snack foods. Pharmacol Biochem Behav 83(2):257-64 
 
Jennes L, Stumpf WE, Kalivas PW 1982 Neurotens topographical distribution in rat 
brain by immunohistochemistry. J. Neurol Comp. 210:211-224 
 
Jones BE 2005 From waking to sleeping: neuronal and chemical substrates. Trends 
Pharmacol Sci 26:578–586 
 
Kalra SP, Dube MG, Pu S, Xu B, Horvath TL,  Kalra PS 1999 Interacting appetite-
regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 
20:68-100 
 
Kapp BS, FRysinger RC, Gallagher M, Haselton JR 1979 Amygdala central nucleus 
lesions: effect on heart rate conditioning in the rabbit Physio Behav 23:1109-1117 
 
Kaur S, Thankachan S, Begum S, Liu M, Blanco-Centurion C, Shiromani PJ 2009 
Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) 
increase REM sleep in hypocretin knockout mice. PLoS One 4(7):e6346 
 
King SO 2nd, Williams CL 2009 Novelty-induced arousal enhances memory for cued 
classical fear conditioning: interactions between peripheral adrenergic and brainstem 
glutamatergic systems Learn Mem 16(10):625-34 
 
Kinney GG, Kocsis B, Vertes RP 1995 Injections of muscimol into the median raphe 
nucleus produce hippocampal theta rhythm in the urethane anesthetized rat. 
Psychopharmacology 120:244–248 
 
Kinney GG, Kocsis, Vertes RP 1995 Injections of muscimol into the median raphe 
nucleus produce hippocampal theta rhythm in the urethane anesthetized rat. 
Psychopharmacology 120:244-248 
 
                                    
116 
 
Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A, O'Dell LE, Parsons 
LH, Sanna PP 2004 Neurobiological mechanisms in the transition from drug use to 
drug dependence. Neurosci Biobehav Rev 27(8):739-749 
 
Koob GF, Heinrichs SC 1999 A role for corticotropin releasing factor and urocortin in 
behavioral responses to stressors. Brain Res 848(1-2):141-152 
 
Korte SM, De Boer SF 2003 A robust animal model of state anxiety: fear-potentiated 
behaviour in the elevated plus-maze. Eur J Pharmacol 463(1-3):163-175 
 
Kuei C, Sutton S, Bonaventure P 2007 R3(BDelta23 27)R/I5 chimeric peptide, a 
selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro 
and in vivo characterization. J Biol Chem 282:25425-25435 
 
Kuei C, Sutton S, Bonaventure P, Pudiak C, Shelton J, Zhu J, Nepomuceno D, Wu J, 
Chen J, Kamme F, Seierstad M, Hack MD, Bathgate RA, Hossain MA, Wade JD, 
Atack J, Lovenberg TW, Liu C 2007 R3(BDelta23 27)R/I5 chimeric peptide, a 
selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro 
and in vivo characterization. J Biol Chem 282(35):25425-25435 
 
LeDoux JE, Iwata J, Cicchetti P, Reis DJ 1988 Different projections of the central 
amygdaloid nucleus mediate autonomic and behavioural correlates of conditioned fear 
J Neurosci 8:2517-2529 
 
Lein, E. S., Hawrylycz, M. J., Ao, N. et al. (2007) Genome-wide atlas of gene 
expression in the adult mouse brain. Nature 445:168-176. 
 
Li AJ, Dinh TT, Ritter S 2008 Hyperphagia and obesity produced by arcuate injection 
of NPY-saporin do not require upregulation of lateral hypothalamic orexigenic 
peptide genes. Peptides 29(10):1732-1739 
 
Li HY, Sawchenko PE 1998 Hypothalamic effector neurons and extended circuitries 
activated in "neurogenic" stress: a comparison of footshock effects exerted acutely, 
                                    
117 
 
chronically, and in animals with controlled glucocorticoid levels. J Comp Neurol 
393(2):244-266 
 
Liberzon I, Taylor SF, Amdur R, Jung TD, Chamberlain KR, Minoshima S et al 1999 
Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry 
45:817–826 
 
Lim L, Ng TP, Chua HC, Chiam PC, Won V, Lee T, Fones C, Kua EH 2005 
Generalised anxiety disorder in Singapore: prevalence, co-morbidity and risk factors 
in a multi-ethnic population. Soc Psychiatry Psychiatr Epidermiol 40: 972-979 
 
Liu C, Chen J, Kuei C, Sutton S, Nepomuceno D, Bonaventure P, Lovenberg TW 
2005a Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G 
protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-
containing G protein-coupled receptor 7. Mol Pharmacol 67:231-240 
 
Liu C, Chen J, Sutton S, Roland B, Kuei C, Farmer N, Sillard R, and Lovenberg T. W 




Liu C, Eriste E, Sutton S, Chen J, Roland B, Kuei C, Farmer N, Jornvall H, Sillard R, 
Lovenberg TW 2003b Identification of relaxin-3/INSL7 as an endogenous ligand for 
the orphan G-protein-coupled receptor GPCR135. J. Biol. Chem. 278:50754-50764 
 
Liu C, Kuei C, Sutton S 2005b INSL5 is a high affinity specific agonist for GPCR142 
(GPR100). J Biol Chem 280:292-300 
 
Lorberbaum JP, Kose S, Johnson MR, Arana GW, Sullivan LK, Hamner MB et al 
2004 Neural correlates of speech anticipatory anxiety in generalized social phobia. 
Neuroreport 15:2701-2705 
 
Lucca G, Comim CM, Valvassori SS, Pereira JG, Stertz L, Gavioli EC, Kapczinski F, 
Quevedo J 2008 Chronic mild stress paradigm reduces sweet food intake in rats 
                                    
118 
 
without affecting brain derived neurotrophic factor protein levels. Curr Neurovasc 
Res 5(4):207-213 
 
Ma S, Blasiak A, Olucha-Bordonau FE, Verberne AJ, Gundlach AL 2013 
Heterogeneous responses of nucleus incertus neurons to corticotrophin-releasing 
factor and coherent activity with hippocampal theta rhythm in the rat. J Physiol 
591(16):3981-4001 
 
Ma S, Bonaventure P, Ferraro T, Shen PJ, Burazin TCD, Bathgate RAD, Liu C, 
Tregear GW, Sutton SW, Gundlach AL 2007 Relaxin-3 in GABA projection neurons 
of the nucleus incertus suggest widespread influence on forebrain circuits via G-
protein-coupled receptor-135 in the rat. Neuroscience 144:165-190 
 
Ma S, Olucha-Bordonau FE, Hossain MA, Lin F, Kuei C, Liu C, Wade JD, Sutton 
SW, Nunez A, Gundlach AL 2009a Modulation of hippocampal theta oscillations and 
spatial memory by relaxin-3 neurons of the nucleus incertus. Learn Mem 16:730-742 
 
Ma S, Roozendaal B, Burazin TC, Tregear GW, McGaugh JL, Gundlach AL 2005 
Relaxin receptor activation in the basolateral amygdala impairs memory 
consolidation. Eur J Neurosci 22:2117-2122 
 
Ma S, Sang Q, Lanciego JL, Gundlach AL 2009 Localization of relaxin-3 in brain of 
Macaca fascicularis: Identification of a nucleus incertus in primate. The Journal of 
Comparative Neurology 517:856-872 
 
Ma S, Shen PJ, Burazin TC, Tregear GW, Gundlach AL 2006 Comparative 
localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) 
mRNA and [33P]-relaxin binding sites in rat brain: restricted somatic co-expression a 
clue to relaxin action? Neuroscience 141:329-344 
 
Maciejewski-Lenoir D, Heinrichs SC, Liu XJ, Ling N, Tucker A, Xie Q, Lappi DA, 
Grigoriadis DE 2000 Selective impairment of corticotropin-releasing factor1 (CRF1) 
receptor-mediated function using CRF coupled to saporin. Endocrinology 141(2):498-
504. 




Macklis JD 1993 Transplanted neocortical neurons migrate selectively into regions of 
neuronal degeneration produced by chromophore-targeted laser photolysis. J Neurosci 
13(9):3848-3463 
 
Madison RD, Macklis JD 1993 Noninvasively induced degeneration of neocortical 
pyramidal neurons in vivo: selective targeting by laser activation of retrogradely 
transported photolytic chromophore. Exp Neurol 121(2):153-159 
 
Madison RD, Macklis JD, Frosch MP 1988 Non-invasive laser microsurgery 
selectively damages populations of labeled mouse neurons: dependence on incident 
laser dose and absorption. Brain Res 445(1):101-110 
 
Magavi SS, Leavitt BR, Macklis JD 2000 Induction of neurogenesis in the neocortex 
of adult mice. Nature 405(6789):951-955 
 
Matsumoto M, Kamohara M, Sugimoto T, Hidaka K, Takasaki J, Saito T, Okada M, 
Yamaguchi T and Furuichi K 2000 The novel G-protein coupled receptor SALPR 
shares sequence similarity with somatostatin and angiotensin receptors. Gene 
248:183-189 
 
McGowan BM, Stanley SA, Smith KL 2005 Central relaxin-3 administration causes 
hyperphagia in male Wistar rats. Endocrinology 146:3295-3300 
 
McGowan BM, Stanley SA, Smith KL 2006 Effects of acute and chronic relaxin-3 on 
food intake and energy expenditure in rats. Regul Pept 136:72-77 
 
McGowan BM, Stanley SA, White NE 2007 Hypothalamic mapping of orexigenic 
action and Fos-like immunoreactivity following relaxin-3 administration in male 
Wistar rats. Am J Physiol Endocrinol Metab 292:913-919 
 
Milad MR, Rauch SL, Pitman RK, Quirk GJ 2006 Fear extinction in rats: implications 
for human brain imaging and anxiety disorders. Biol Psychol 73(1):61-71 
 
                                    
120 
 
Min G, Sherwood OD 1998 Localization of specific relaxin-binding cells in the ovary 
and testis of pigs. Biol Reprod 59:401-408 
 
Miyamoto Y, Watanabe Y, Tanaka M 2008 Developmental expression and 
serotonergic regulation of relaxin 3/INSL7 in the nucleus incertus of rat brain. Regul 
Pept 145:54-99 
 
Mohseni P, Najafi K, Eliades SJ, Wang X 2005 Wireless multichannel biopotential 
recording using an integrated FM telemetry circuit. IEEE Trans Neural Syst Rehabil 
Eng 13(3):263-271 
 
Monk CS, Telzer EH, Mogg K, Bradley BP, Mai X, Louro HM et al 2008 Amygdala 
and ventrolateral prefrontal cortex activation to masked angry faces in children and 
adolescents with generalized anxiety disorder. Arch Gen Psychiatry 65:568-576 
 
Monti JM, Jantos H 2008 The roles of dopamine and serotonin, and of their receptors, 
in regulating sleep and waking. Prog Brain Res 172:625-646 
 
Moruzzi G, Magoun HW 1949 Brain stem reticular formation and activation of the 
EEG Electroencephalograph. Clin Neurophysiol 1:455–473 
 
Murray CKL, Lopez AD 1997 Global mortality, disability and the contribution of risk 
factors: Global burden of disease study. Lancet 349:1347-1352 
 
Nag N, Baxter MG, Berger-Sweeney JE 2009 Efficacy of a murine-p75-saporin 
immunotoxin for selective lesions of basal forebrain cholinergic neurons in mice. 
Neurosci Lett 452(3):247-251 
 
Nakazawa CM, Shikata K, Uesugi M, Katayama H, Aoshima K, Tahara K, Takahashi 
E, Hida T, Shibata H, Ogura H, Seiki T, Oda Y, Kuromitsu J, Miyamoto N 2013 
Prediction of relaxin-3-induced downstream pathway resulting in anxiolytic-like 
behaviors in rats based on a microarray and peptidome analysis. J Recept Signal 
Transduct Res 33(4):224-233 
 
                                    
121 
 
Naumann T, Härtig W, Frotscher M 2000 Retrograde tracing with Fluoro-Gold: 
different methods of tracer detection at the ultrastructural level and neurodegenerative 
changes of back-filled neurons in long-term studies. J Neurosci Methods 103(1):11-21 
 
Nesbitt PD 1973 Smoking, physiological arousal, and emotional response. J Pers Soc 
Psychol 25(1):137-144 
  
Nunez A, Cervera-Ferri A, Olucha-Bordonau F, Ruiz-Torner A, Teruel V 2006 
Nucleus incertus contribution to hippocampal theta rhythm generation. Eur J Neurosci 
23:2731-2738 
 
Okamura N, Reinscheid RK 2007 Neuropeptide S: a novel modulator of stress and 
arousal. Stress 10(3):221-226 
 
Olivier JD, Vallès A, van Heesch F, Afrasiab-Middelman A, Roelofs JJ, Jonkers M, 
Peeters EJ, Korte-Bouws GA, Dederen JP, Kiliaan AJ, Martens GJ, Schubert D, 
Homberg JR 2011 Fluoxetine administration to pregnant rats increases anxiety-related 
behavior in the offspring. Psychopharmacology (Berl) 217(3):419-432 
 
Olivier JD, Van Der Hart MG, Van Swelm RP, Dederen PJ, Homberg JR, Cremers T, 
Deen PM, Cuppen E, Cools AR, Ellenbroek BA 2008 A study in male and female 5-
HT transporter knockout rats: an animal model for anxiety and depression disorders. 
Neuroscience 152(3):573-584 
 
Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I,  Barsh GS 1997 
Antagonism of central melanocortin receptors in vitro and in vivo by agoutirelated 
protein. Science 278:135-138 
 
Olucha-Bordonau FE, Teruel V, Barcia-Gonzalez J, Ruiz-Torner A, Valverde-
Navarro AA, Martinez-Soriano F 2003 Cytoarchitecture and efferent projections of 
the nucleus incertus of the rat. J. Comp. Neurol. 464:62-97 
 
Parry LJ, Vodstrcil LA 2007 Relaxin physiology in the female reproductive tract 
during pregnancy. Adv Exp Med Biol 612:34-48 




Pascual J, Heinrichs SC 2007 Olfactory neophobia and seizure susceptibility 
phenotypes in an animal model of epilepsy are normalized by impairment of brain 
corticotropin releasing factor. Epilepsia 48(4):827-833 
 
Paxinos G, Carrive P, Wang H, Wang PY 1999 Chemoarchitectonic atlas of the rat 
brainstem. Academic Press, San Diego California. 
 
Paxinos G, Watson C 2007 The rat brain in stereotaxic coordinates, sixth ed. 
Academic Press, London 
 
Pedemonte M, Barrenechea C, Nuñez A, Gambini JP, García-Austt E 1998 Membrane 
and circuit properties of the lateral septum neurons: relationships with hippocampal 
rhythms. Brain Res 800(1):145-153 
 
Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F 
1995 Effects of the obese gene product on body weight regulation in ob/ob mice. 
Science 269:540-543 
 
Pellow S, Chopin P, File SE, Briley M 1985 Validation of open:closed arm entries in 
an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 
14(3):149-167. 
 
Pellow S, File SE 1986 Anxiolytic and anxiogenic drug effects on exploratory activity 
in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 
24(3):525-529 
 
Pereira CW, Santos FN, Sanchez-Perez AM, Otero-Garcia M, Marchiro M, Ma S, 
Gundlach AL, Olucha-Bordonau 2013 Electrolytic lesion of the nucleus incertus 
retards extinction of auditory conditioned fear Behav Brain Res 247:201-210 
 
Pfaff D 2006 Brain Arousal and Information Theory. Neural and Genetic 
Mechanisms. Harvard University Press, Cambridge, Massachusetts and London, 
England 




Phan KL, Britton JC, Taylor SF, Fig LM, Liberzon I 2006a Corticolimbic blood flow 
during nontraumatic emotional processing in posttraumatic stress disorder. Arch Gen 
Psychiatry 63:184-192 
 
Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale W 
1994 Distribution of corticotropin-releasing factor receptor mRNA expression in the 
rat brain and pituitary. Proc. Natl. Acad. Sci. U.S.A. 91:8777-8781 
 
Prut L, Belzung C 2003 The open field as a paradigm to measure the effects of drugs 
on anxiety-like behaviors: a review. Eur J Pharmacol 463(1-3):3-33 
 
Ramakrishnan S, Houston LL 1984 Comparison of the selective cytotoxic effects of 
immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 
1.1 monoclonal antibodies. Cancer Res 44(1):201-208 
 
Ressler KJ, Nemeroff CB 2000 Role of serotonergic and noradrenergic systems in the 
pathophysiology of depression and anxiety disorders. Depress Anxiety 12 Suppl 1:2-
19 
 
Roozendaal B, McEwen BS, Chattarji S 2009 Stress, memory and the amygdala. Nat 
Rev Neurosci 10(6):423-433 
 
Ryan PJ, Büchler E, Shabanpoor F, Hossain MA, Wade JD, Lawrence AJ, Gundlach 
AL 2013 Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and 
depressive-like behaviours in the rat. Behav Brain Res 244:142-151 
 
Ryan PJ, Ma S, Olucha-Bordonau FE, Gundlach AL 2011 Nucleus Incertus – An 
emerging modulatory role in arousal, stress and memory. Neuroscience and 
Biobehavioural Reviews 35: 1326-1341 
 
Samuel CS,  Hewitson TD 2009 Relaxin and the progression of kidney disease. Curr 
Opin Nephrol Hypertens 18:9-14. 
 
                                    
124 
 
Santanché S, Bellelli A, Brunori M 1997 The unusual stability of saporin, a candidate 
for the synthesis of immunotoxins.  Biochem Biophys Res Commun 234(1):129-132 
 
Saper CB, Scammell TE, Lu J 2005 Hypothalamic regulation of sleep and circadian 
rhythms. Nature 437:1257-1263 
 
Sapra P, Shor B 2013 Monoclonal antibody-based therapies in cancer: advances and 
challenges. Pharmacol Ther (3):452-469 
 
Senba E, Matsunaga K, Tohyama M, Noguchi K 1993 Stress-induced c-fos 
expression in the rat brain: activation mechanism of sympathetic pathway. Brain 
Research Bull 31(3-4):329-344 
 
Seon BK 1984 Specific killing of human T-leukemia cells by immunotoxins prepared 
with ricin A chain and monoclonal anti-human T-cell leukemia antibodies. Cancer 
Res 44(1):259-264 
 
Shader RI, Greenblatt DJ 1993 Use of benzodiazepines in anxiety disorders. N Engl J 
Med 328(19):1398-1405 
 
Shin LM, Kosslyn SM, McNally RJ, Alpert NM, Thompson WL, Rauch SL 1997 
Visual imagery and perception in posttraumatic stress disorder. A positron emission 
tomographic investigation. Arch Gen Psychiatry 54:233-241 
 
Shin LM, Liberzon I 2010 The neurocircuitry of fear, stress and anxiety disorders 
Neuropsychopharmacology 35:169-191 
 
Silva RC, Brandão M 2000 Acute and chronic effects of gepirone and fluoxetine in 
rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem 
Behav 65(2):209-16 
 
Smith CM, Hosken IT, Sutton SW, Lawrence AJ, Gundlach AL 2012 Relaxin-3 null 
mutation mice display a circadian hypoactivity phenotype. Genes Brain Behav 
11(1):94-104 
                                    
125 
 
Smith CM, Lawrence AJ, Sutton SW, Gundlach AL 2009a Behavioural phenotyping 
of mixed background (129S5:B6) relaxin-3 knockout mice. Relaxin and Related 
Peptides: Fifth International Conference: Ann. N.Y Acad 1160: 236-241 
 
Smith CM, Ryan PJ, Hosken IT, Ma S, Gundlach AL 2011 Relaxin-3 systems in the 
brain--the first 10 years. J Chem Neuroanat 42(4):262-275 
 
Smith CM, Shen PJ, Banerjee A, Bonaventure P, Ma S, Bathgate RAD, Sutton SW, 
Gundlach AL 2010 Distribution of relaxin-3 and RXFP3 within arousal, stress, 
affective, and cognitive circuits of mouse brain. J Comp Neurol 518:4016-4045 
 
Smith CM, Shen PJ, Ma S, Sutton SW, Gundlach AL 2009b Verification of a relaxin-
3 knockout/LacZ reporter mouse as a model of relaxin-3 deficiency. Relaxin and 
Related Peptides: Fifth International Conference: Ann. N.Y Acad 1160: 259-260 
 
Smith KL, Patterson M, Dhillo WS, Patel SR, Semjonous NM, Gardiner JV, Ghatei 
MA, Bloom SR 2006 Neuropeptide S stimulates the hypothalamo-pituitary-adrenal 
axis and inhibits food intake. Endocrinology 147(7):3510-3518 
 
Srebro B, Lorens SA 1975 Behavioral effects of selective midbrain raphe lesions in 
the rat. Brain Res 89:303-325 
 
Stanley BG, Leibowitz SF 1984 Neuropeptide Y: stimulation of feeding and drinking 
by injection into the paraventricular nucleus. Life Sci 35:2635-2642 
 
Stanley BG, Leibowitz SF 1985 Neuropeptide Y injected in the paraventricular 
hypothalamus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci U S A 
82:3940-3943 
 
Stephens TW, Basinski M, Bristow PK 1995 The role of neuropeptide Y in the 
antiobesity action of the obese gene product. Nature 377:530-532 
 
Stirpe F, Gasperi-Campani A, Barbieri L, Falasca A, Abbondanza A, Stevens WA 
1983 Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. 
                                    
126 
 
(soapwort), of Agrostemma githago L. (corn cockle) and of Asparagus officinalis L. 
(asparagus), and from the latex of Hura crepitans L. (sandbox tree) Biochem J 16(3): 
617-625 
 
Stratford EW, Bostad M, Castro R, Skarpen E, Berg K, Høgset A, Myklebost O, 
Selbo PK 2013 Photochemical internalization of CD133-targeting immunotoxins 
efficiently depletes sarcoma cells with stem-like properties and reduces 
tumorigenicity. Biochim Biophys Acta 1830(8):4235-4243 
 
Streeter GL 1903 Anatomy of the floor of the fourth ventricle. Am J Anat 2:299-319 
 
Subramaniam M, Picco L, He V, Vaingankar JA, Abdin E,Verma S, Rekhi G, Yap M, 
Lee J, Chong SA Body mass index and risk of mental disorders in the general 
population: Results from the Singapore Mental Health Study. Journal of 
Psychosomatic Research 74: 135-141 
 
Suda T, Tozawa F, Iwai I, Sato Y, Sumitomo T, Nakano Y, Yamada M, Demura H 
1993 Neuropeptide Y increases the corticotropin-releasing factor messenger 
ribonucleic acid level in the rat hypothalamus. Brain Res Mol Brain Res 18(4):311-
315 
 
Summerlee AJ, O'Byrne KT, Paisley AC, Breeze MF,  Porter DG 1984 Relaxin 
affects the central control of oxytocin release Nature 309:372-374 
 
Sunn N, Egli M, Burazin TC 2002 Circulating relaxin acts on subfornical organ 
neurons to stimulate water drinking in the rat. Proc Natl Acad Sci U S A 99:1701-
1706. 
 
Sutin EL, Jacobowitz DM 1988 Immunocytochemical localization of peptides and 
other neurochemicals in the rat laterodorsal tegmental nucleus and adjacent area. J. 
Comp. Neurol. 270:243-270 
 
Sutton RE, Koob GF, Le Moal M, Rivier J, Vale W 1982 Corticotropin releasing 
factor produces behavioural activation in rats. Nature 297(5864):331-333 




Sutton SW, Bonaventure P, Kuei C, Nepomuceno D, Wu J, Zhu J, Lovenberg TW and 
Liu C 2006 G-Protein-Coupled Receptor (GPCR)-142 does not contribute to relaxin-3 
binding in the mouse brain: further support that relaxin-3 is the physiological ligand 
for GPCR135. Neuroendocrinology  82:139-150. 
 
Sutton SW, Bonaventure P, Kuei C, Roland B, Chen J, Nepomuceno D, Lovenberg 
TW,  Liu C 2004 Distribution of G-protein-coupled receptor (GPCR)135 binding sites 
and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine 
and sensory processing. Neuroendocrinology 80:298-307 
 
Sutton SW, Shelton J, Smith C 2009 Metabolic and neuroendocrine responses to 
RXFP3 modulation in the central nervous system. Ann N Y Acad Sci 1160:242-249 
Swanson LW, Sawchenko PE 1983 Hypothalamic integration: organization of the 
paraventricular and suproptic nuclei. Annu Rev Neurosci. 6:269-324 
 
Tanaka M, Iijima N, Miyamoto Y, Fukusumi S, Itoh Y, Ozawa H, Ibata Y 2005 
Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress. Eur. J. 
Neurosci. 21:1659-1670 
 
Thorpe PE, Brown AN, Bremner JA Jr, Foxwell BM, Stirpe F 1985 An immunotoxin 
composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein 
from Saponaria officinalis: potent antitumor effects in vitro and in vivo.  J Natl 
Cancer Inst 75(1):151-159 
 
Tillfors M, Furmark T, Marteinsdottir I, Fischer H, Pissiota A, Langstrom B et al 
2001 Cerebral blood flow in subjects with social phobia during stressful speaking 
tasks: a PET study. Am J Psychiatry 158:1220-1226 
 
Turner LH, Lim CE, Heinrichs SC 2007 Antisocial and seizure susceptibility 
phenotypes in an animal model of epilepsy are normalized by impairment of brain 
corticotropin-releasing factor. Epilepsy Behav 10(1):8-15 
 
                                    
128 
 
Valenstein ES, Cox VC, Kakolewski JW 1968 Modification of motivated behaviour 
elicited by electrical stimulation of the hypothalamus. Science 159:1119-1121 
 
van den Heuvel OA, Veltman DJ, Groenewegen HJ, Witter MP, Merkelbach J, Cath 
DC et al 2005b Disorder-specific neuroanatomical correlates of attentional bias in 
obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen 
Psychiatry 62:922-933 
 
van der Westhuizen ET, Werry TD, Sexton PM, Summers RJ 2007 The relaxin family 
peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein 
kinase C-dependent mechanism. Mol. Pharmacol. 71:1618-1629 
 
Van Pett K, Viau V, Bittencourt JC 2000 Distribution of mRNAs encoding CRF 
receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212 
Vertes RP 2005 Hippocampal theta rhythm: a tag for short-term memory. 
Hippocampus 15:923–935 
 
Vertes RP, Hoover WB, Viana Di Prisco G 2004 Theta rhythm of the hippocampus: 
subcortical control and functional significance Behav Cogn Neurosci Rev 3(3):173-
200 
 
Vertes RP, Kocsis B 1997 Brainstem-diencephalo-septohippocampal systems 
controlling the theta rhythm of the hippocampus Neurosci 81(4):893-926 
 
Viana Di Prisco G, Albo Z, Vertes RP, Kocsis B 2002 Discharge properties of 
neurons of the median raphe nucleus during hippocampal theta rhythm in the rat. Exp 
Brain Res 145:383-394 
 
Wada E, Way J, Lebacq-Verheyden AM, Battey JF 1990 Neuromedin B and gastrin-
releasing peptide RNAs are differentially distributed in the rat nervous system. J. 
Neurosci. 10:2917-2930 
 
Walker HC,  Romsos DR 1993 Similar effects of NPY on energy metabolism and on 
plasma insulin in adrenalectomized ob/ob and lean mice. Am J Physiol 264:226-230 
                                    
129 
 
Walsh RN, Cummins RA 1976 The Open-Field Test: a critical review. Psychol Bull 
83(3):482-504 
 
Watanabe Y, Tsujimura A, Takao K, Nishi K, Ito Y, Yasuhara Y, Nakatomi Y, 
Yokoyama C, Fukui K, Miyakawa T, Tanaka M 2011a Relaxin-3-deficient mice 
showed slight alteration in anxiety-related behavior. Front Behav Neurosci 5:50 
 
Watanabe Y, Miyamoto A, Matsuda T and Tanaka M 2011b Relaxin-3/INSL7 
regulates the stress-response system in the rat hypothalamus. J Mol Neurosci 43: 169 - 
174 
 
Wiley RG 1992 Neural lesioning with ribosome-inactivating proteins: suicide 
transport and immunolesioning. Trends Neurosci 15(8):285-290 
 
Wirtshafter D, Asin KE 1982 Evidence that electrolytic median raphe lesions increase 
locomotion but not exploration. Physiol Behav 28:749-754 
 
Wyss JM, Swanson LW, Cowan WM 1979 A study of subcortical afferents to the 























Lee LC, Ramamoorthy R, Dawe GS Selective lesioning of nucleus incertus with 
corticotrophin releasing factor-saporin conjugate. Behav Brain Res (Accepted/In 
Press) 
 
7.2 Poster presentations 
 
1:  Title: The nucleus incertus plays a role in the regulation of stress/anxiety in rodents 
Authors: Lee Liying Corinne, Rajkumar Ramamoorthy, Gavin Dawe Abstract no: 
P044 Conference name: Yong Loo Lin School of Medicine Graduate Scientific 
Congress 2011 Conference Venue:  National University of Singapore Conference 
date: 25 January 2011 
 
2. Title: The nucleus incertus contributes to the anxiety-like behaviour in rats 
Authors: Lee Liying Corinne, Rajkumar Ramamoorthy, Sana Suri, Chin Wai Mun 
Eunice, Gavin Dawe Abstract no: 901.09/JJ3 Conference name: Neuroscience 2011 
Conference venue: Washington DC Conference date:  12th - 16th November 2011 
 
3. Title: The nucleus incertus contributes to the anxiety-like behaviour in rats 
Authors: Lee Liying Corinne, Rajkumar Ramamoorthy, Sana Suri, Gavin Dawe 
Abstract no: P108 Conference name: Yong Loo Lin School of Medicine Graduate 
Scientific Congress 2012 Conference Venue:  National University of Singapore 
Conference date: 15 February 2012 
 
4. Title: The nucleus incertus plays a role in regulating fear and anxiety responses in 
rats 
Authors: Lee Liying Corinne, Rajkumar Ramamoorthy, Gavin Dawe Abstract no: P11 
Conference name: 6th International conference on Relaxin and related peptides 
Conference venue: Florence, Italy Conference date: 8th - 12th October 2012 
